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ABSTRACT 
The epicardium, the heart’s outermost layer, contains progenitors for 
essential non-cardiomyocyte lineages that support coronary vascular 
development. The Hippo pathway, a conserved kinase cascade, controls organ 
size in the developing heart and inhibits regeneration in the adult heart. In the first 
study, using high-throughput single cell RNA-seq (scRNA-seq), we investigated 
the function of Hippo pathway kinases, Lats1 and Lats2 (Lats1/2) in epicardial 
development. Lats1/2 mutant cells fail to activate the fibroblast differentiation 
program, but instead remain suspended in an intermediate progenitor cell state 
with characteristics of epicardial cells and fibroblasts. Computational analysis and 
lineage tracing revealed an arrested developmental trajectory for Lats1/2 mutant 
cells that resulted in an abnormal extracellular matrix composition and an altered 
extracellular growth factor milieu, leading to defective coronary vascular 
remodeling.  
In the second study, we focused on the minor lineage endothelial cell which 
rarely comes from epicardium at normal state. Lats mutant epicardium 
preferentially generated endothelial cells. Genes associated with F-actin 
polymerization were upregulated in Lats mutant epicardium. Super-resolution 
microscopy and atomic force microscopy indicated that Lats mutant epicardium 
was stiffer with more intracellular F-actin bundles. Explant studies revealed that 
epicardial progenitors cultured on stiff matrices acquired an endothelial phenotype 
independently of Lats , while on softer, more physiologic matrices Lats inhibited 
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the endothelial phenotype. Thus, Lats inhibits Wt1 derived endothelial lineage 
expansion in cooperation with cytoskeletal state.   
In the third study, we investigated the role of Lats1/2 in adult cardiac 
fibroblast. Inactivation of Lats1/2 in fibroblasts resulted in hyper-proliferation of 
cardiac fibroblast. Lats1/2CKO hearts also showed reduced collagen production 
after injury, suggesting defective injury response. We compared the transcriptome 
of these two groups at homeostasis without surgery. Interestingly, interferon 
responding genes and genes associated with T cell activation were decreased, 
suggesting common cross-talk between fibroblasts and immune cells at resting 
condition. To be noted, these Lats1/2 mutant fibroblasts exhibited pronounced 
Myc expression, which were accompanied with significant apoptosis in 
surrounding cells, suggesting cell competition between Lats1/2 mutant cells and 
neighboring “wild type” cells. Taken together, our study revealed a pivotal role of 
Lats kinase in heart homeostasis maintenance and injury response.  
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CHAPTER I 
 INTRODUCTION 
Heart disease is the leading cause of death in developed world. Since adult 
mammalian heart has very limited regeneration ability, heart muscle once 
damaged is often accompanied with fibrotic scar which results cardiac function 
decline. Current studies have been searching efficient therapeutics to reverse or 
alleviate this disease progress from the aspects as follows. Firstly, although adult 
mammalian heart is considered as a post-mitotic organ, several group have 
shown that cardiomyocyte indeed undergo slow turnover rate. This observation 
offered us a great hint of manipulating cardiomyocyte growth to promote heart 
repair.  Secondly, stem cell therapy for other organ has raised a tremendous hope 
of replenishing functioning cells after injury. The question that whether stem cell 
exists in adult heart is still debatable. Nonetheless, several cell types, such as 
epicardial cells, with higher plasticity indeed exert reparative function after heart 
injury. Thirdly, as the main source of fibrosis after heart insult, cardiac fibroblast 
has been shown to participate initial adaptive phase to prevent heart rupture as 
well as the later maladaptive phase of heart remodeling. Studies have 
demonstrated that either reprogramming fibroblast into cardiomyocyte, or 
manipulating fibroblast per se, can be an exciting path to promote heart repair.  
Here in our study, we are going to focus on the latter two aspects.  
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Hippo signaling is an ancient signaling pathway controlling organ size 
through modulating cell proliferation and differentiation. Its components include 
ste-20 family kinases Mst1 and Mst2 (Mst1/2), which complex with the scaffold 
adaptor protein Salvador (Salv) to phosphorylate the nuclear dbf2-related (NDR) 
family kinases Lats1 and Lats2 (Lats1/2). Yap and Taz, the Hippo pathway 
effectors, are transcriptional co-factors that are substrates for Lats1/2 kinases. 
Upon phosphorylation by Lats1/2 kinases, Yap and Taz are excluded from the 
nucleus and their transcriptional activity is inhibited. Work from our lab revealed 
that removing Hippo pathway components in the embryonic or adult myocardium 
releases the downstream effector Yap from Hippo-dependent suppression, 
promoting cardiomyocyte proliferation and tissue regeneration (1-3).  
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CHAPTER II  
SINGLE CELL TRANSCRIPTOMICS REVEAL AN ESSENTIAL ROLE FOR 
HIPPO SIGNALING IN CELL STATE TRANSITIONS DURING CARDIAC 
FIBROBLAST DEVELOPMENT 
Introduction 
Embryonic epicardium originates from pro-epicardium. At mouse 
embryonic day (E)9.5, proepicardial cells attach to myocardium and spread as a 
continuous epithelial sheet over the myocardium. A subset of epicardial cells 
delaminate from the epicardium, undergo epithelial mesenchymal transition, and 
generate EPDC (4). Although epicardial cells are quiescent in the adult, they are 
activated upon injury and contribute to the repair process in part by modulating 
the inflammatory response. The activated epicardium post-injury expresses many 
developmental genes indicating that developmental programs are reactivated 
after injury in the adult heart (5,6). This reactivation of developmental programs 
has considerable clinical significance since the adult epicardium is also the source 
of pro-inflammatory signals that regulate the amount of fibrosis after myocardial 
infarction.  
During heart development, subset of epicardial cells delaminate from the 
epicardium, undergo epithelial to mesenchymal transition (EMT) and generate 
epicardial-derived cells (EPDCs). EPDCs first populate the subepicardial space 
between epicardium and myocardium, forming the subepicardial mesenchyme, 
and then invade the myocardium where they differentiate into the essential 
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supporting cells of the heart (4). In mammals, EPDCs derived from the Wt1-
expressing lineage primarily give rise to vascular smooth muscle cells and 
fibroblasts, two supporting cell types that are important for coronary vascular and 
myocardial development.  
The Hippo signaling pathway is a conserved organ size control pathway 
that inhibits cell proliferation and promotes apoptosis (7). Work from our lab 
revealed that removing Hippo pathway components in the embryonic or adult 
myocardium releases the downstream effector Yap from Hippo-dependent 
suppression, promoting cardiomyocyte proliferation and tissue regeneration (1-3).  
Here, we used single cell transcriptomics to investigate Lats1/2 function in 
epicardial progenitor cell diversification. A high-throughput single cell (sc) RNA-
sequence (seq) platform, Drop-seq, was adopted for the first time to characterize 
E13.5 and E14.5 cardiac cellular composition and heterogeneity at high resolution 
in Lats1/2 deficient and control hearts (8). Importantly, our data revealed that 
Lats1/2 activity is required for EPDC progression from a transient subepicardial 
mesenchymal phenotype to a fully differentiated cardiac fibroblast identity. 
Materials and Methods 
Mice 
Wt1CreERT2 (9), Lats1/2flox/flox (3), Yap/Taz flox/flox(10),Rosa26mTmG (11) alleles 
have been described previously. Mice were on a mixed genetic background of 
C57BL/6 and 129SV. Tamoxifen was dissolved in peanut oil with 5% ethanol at 
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10mg/ml. For Wt1CreERT2, 0.1mg/g body weight tamoxifen was administrated to 
plugged female by intraperitoneal injection at embryonic (E) day 11.5.  
Cell preparation and Drop-seq workflow 
Atria were removed prior to single cell suspension preparation, droplet 
generation, cDNA amplification, and library preparation.  Following sequencing of 
Drop-seq libraries, a minimum gene per cell threshold of 500 was set for inclusion 
into the data set resulting in a final digital gene expression matrix with a median 
of 1,005 genes per cell and 1,500 Unique Molecular Identifiers (UMI) per cell (Fig. 
S2A). Batch effects were corrected for and principle components analysis was 
carried out. Cells were dissociated as previously described (12). Hearts were 
chopped into several pieces and digested by 1mg/ml collagenase I for 20 min at 
37°C. Every 10min, the sample was gently pipetted sample up and down to 
mechanically dissociate the cells. 10% FBS in DMEM was applied to quench the 
protease, and samples were passed through a 100µm strainer. Following tissue 
dissociation cells were diluted to a concentration of 150,000 cells/mL in PBS with 
0.1% BSA. Next, Drop-seq was performed according to Macosko et. al (8). Briefly, 
cells were co-encapsulated into nano-liter sized droplets containing barcoded 
microparticles (ChemGenes, catalog number Macosko201110) and lysis buffer 
using a Drop-seq specific microfluidics device (custom made by FlowJEM, 
Toronto, Canada). After droplet breakage, reverse transcription, and exonuclease 
treatment, total cDNA was amplified, pooled, and purified with Ampure XP beads 
and then quality control, quantification and size determination was performed 
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using a Fragment analyzer (Advanced Analytical Technologies, Inc.) for quality 
control, quantification, and size determination. Tagmentation and library 
preparation was performed with the Illumina Nextera XT kit. Final libraries were 
triple purified with a successive Ampure XP based protocol, whereby two 
successive 0.6X (beads to sample ratio) purifications were performed, followed 
by a final 1X purification step. All libraries were sequenced on an Illumina 
Nextseq500 instrument. 
Drop-seq data analysis 
Sequencing data was processed as described in Shekhar et. al. (2016) 
(8,13). Briefly, raw fastq files were converted to BAMs with Picard tools 
(MergeSamFiles) and then used as input for STAR alignment (14), cell barcode 
correction, and digital gene expression (DGE) matrix generation via the Drop-seq 
tools software package (available at http://mccarrolllab.com/dropseq/). Next, 
DGEs from each experiment were merged. We then imported the comprehensive 
DGE into Seurat (version 1.4.0.5) where normalization was performed according 
to package default settings (15). Batch effects were corrected for with the 
application of Combat, from the R SVA package (version 3.18.0), and by further 
regressing out the number of molecules per cell and the percentage of mapped 
mitochondrial reads with the RegressOut function (Seurat package) (16). Next, 
principle components analysis was performed and significant PCs were used as 
input for graph-based clustering. Finally, 2-dimesnsional visualization of the multi-
dimensional data set was done with tSNE(17). Differential expression of the 
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various clusters was also performed with Seurat, using the likelihood-ratio test for 
single cell gene expression (18). For pseudotime analysis, the normalized data 
from the indicated clusters calculated in Seurat was then passed directly into 
Monocle2 (19). The Monocle2 branched expression analysis modeling (BEAM) 
statistical test was utilized to isolate the branch-specific gene expression patterns 
(256 genes with qval <0.1). Motif enrichment analysis was carried out with the 
Cytoscape plug-in iRegulon using the mouse genome’s default parameters (20). 
All gene ontology (GO) analysis was performed with the Metascape tool 
(http://metascape.org) (21).  
Histology, immunofluorescence, and RNA in situ hybridization 
Epicardium-restricted-Lats1/2 mutant embryos (Lats1/2 CKO) were 
generated by crossing Wt1CreERT2 with Lats1/2flox/flox or  Lats1/2flox/flox; Rosa26mTmG. 
Control embryos were generated by crossing Wt1CreERT2 with Rosa26mTmG or Cre 
negative littermate control. For H&E staining and immunofluorescence staining, 
hearts were fixed in 4% PFA overnight at 4°C and dehydrated in a serial ethanol, 
xylene and embedded in paraffin. Sections of 7µm thick sections were stained 
with H&E for histological analyses (22). For some immunofluorescence staining, 
cryosections were used. Antibodies used for immunofluorescence staining were 
as follows: GFP(1:200, Abcam ab290, ab6673), phospho-YAP (1:200, Cell 
signaling technology,4911), Yap(1:200, Novus NB110-583538), PECAM-1(1:100-
1:200, BD Pharmingen 550274), Vimentin (1:200, Abcam, ab92547), Wt1(1:200, 
Abcam, ab89901), Podoplanin (1:200, Developmental Studies Hybridoma Bank, 
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8.1.1) , α -actinin (1:200, Abcam, ab68687), Collagen I (1:200, Abcam, ab21286), 
Dpp4 (1:100, Biolegend, H194-112). To visualize some antigens, Alexa-647 was 
employed. When applications required green and red co-staining, sections were 
pre-treated with 0.3% H2O2 in PBS for 20min at room temperature to quench the 
endogenous GFP and Tomato signals, which come from the Rosa26mTmG reporter 
line.  In some cases, Tyramide Signal Amplification Systems (1:100, Perkin Elmer) 
were used to amplify signal. PECAM-1 whole mount staining was performed as 
previously described (Monica Zamora, 2007, (23)). PECAM-1(1:100) staining was 
followed either by anti-rat-HRP (1:200, Life Technologies, 62-9520) and a DAB kit 
(Vector lab) for color development or anti-rat-Alexa-647 (1:200, Thermo Fisher 
Scientific) for immunofluorescence staining. The vessel pattern was quantified by 
Angiotool. The tissues for RNA in situ hybridization were prepared as described 
above except adding Diethylpyrocarbonate (DEPC) was added to avoid RNAse 
contamination. RNA in situ hybridization was performed by the RNA In Situ 
Hybridization Core at Baylor College of Medicine. The Twist1(24) and Snai2(25) 
probes were previously described. Gross heart images were captured by Zeiss 
SteREO Discovery.V12 microscope. Histology and RNA In Situ images were 
captured by Nikon Eclipse 80i microscope. Immunofluorescence images were 
captured on a Leica TCS SP5 confocal microscope, a Zeiss LSM 780 confocal 
microscope or Nikon A1-Rs inverted laser scanning microscope. Sample size 
labels on the corresponding bar graph indicate the number of hearts being 
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analyzed, otherwise n=3 in all groups. Three fields of views were analyzed in each 
heart.  
EdU incorporation assay 
To study cell proliferation, pregnant females were injected with 0.08mg/g 
body weight EdU 2hr before harvesting embryos. Hearts were processed as 
described above. EdU incorporation was assayed using the Click-it EdU imaging 
kit (Life Technologies). 
FACS analysis  
Cells were dissociated as previously described in the method section of 
“Cell preparation and Drop-seq workflow”. Antibodies used for flowcytometry 
were: PDGFRα (BD Bioscience 562774), isotype conjugated with BV421 (BD 
Bioscience 562602). Cells were analyzed using BD Biosciences CORP Aria I and 
BD Biosciences LSRII and images were processed with FlowJo software.    
Motif analysis and ChIP-q-PCR 
Gene regulatory region information was extracted from GEO database: 
E14.5 H3K27ac (GSM1264374), P0 H3K27ac (GSM1264378) and Heart DHS 
(GSM1014166). TEAD motif was analyzed by Homer.  Chromatin 
immunoprecipitation was performed with an anti-Yap antibody (Novus NB110-
58358) in the MEC1 epicardial cell line (26). Three biological replicates were 
included in each group.  The primers used for detecting TEAD binding region at 
Dhrs3 and Dpp4 are: 
Dpp4 site1-Forward 5’- GGAGGAAGATTATGCACAACAAC -3’;  
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Dpp4 site1-Reserve 5’- TGTGGAGACATGAAAGACTAAGG -3’;  
Dpp4 site2-Forward 5’- GGAGCTCATGAATGCCTGATT -3’;  
Dpp4 site2-Reserve 5’- CTGCAGAAGAACTGTGCTCTTA -3’;  
Dhrs3-Forward 5’- CCTACCCACACAAGACATCAA -3’;  
Results 
Epicardial deletion of Lats1/2 results in defective coronary vessel 
development and embryonic lethality 
We deleted Lats1/2 in epicardium at E11.5 using the Wt1CreERT2 allele. 
Lats1/2 conditional knock out (CKO) embryos were embryonic lethal and failed to 
survive past E15.5 (Fig. 2.1A). At E14.5, gross morphology and histology revealed 
that Lats1/2 CKO hearts appeared normal, but at E15.5 mutant hearts were 
smaller, with less compacted myocardium (Fig. 2.1 B-D). In addition to these 
cardiac defects, mutant embryos displayed severe surface hemorrhages, as well 
as, herniated livers and intestines (Fig. 2.1E-G).  
            E14.5 to E15.5 is a critical developmental window for coronary vessel 
morphogenesis, as the initial vascular plexus remodels to meet the increased 
oxygen demands of the expanding ventricular wall. We examined overall vessel 
patterning by whole-mount PECAM-1 immunostaining at E14.5. In Lats1/2 CKO 
embryos compared to controls, the coronary vasculature was disorganized with 
reduced vessel coverage and decreased density (Fig. 2.2 B). PECAM-1 
immunofluorescence (IF) staining with confocal microscopy revealed that the 
dorsal vasculature exhibited decreased branching (Fig. 2.2 C). Automated 
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quantification also indicated reduced vessel coverage with fewer junctions and 
increased lacunarity (Fig.2.2 D).  
 
 
 
 
Fig. 2.1 Knocking out Lats1/2 leads to embryonic lethality at E15.5. (A) Activity of Cre was 
induced at E11.5 by tamoxifen injection. Lats1/2 CKO survival rate was determined at different 
harvest time series. *P <0.001 between E16.5 and E14.5, Fisher’s exact test. +P <0.05 between 
E16.5 and E15.5, Fisher’s exact test. (B-D) Gross heart morphology and H&E stained sections 
from at E14.5 and E15.5. (E-G) Non-cardiac defects in Lats1/2 CKO at E15.5, including 
hemorrhage (yellow arrowheads) and herniated liver (L) and intestine (I). Scale bar: B 400µm; C 
left panel 400 µm; right panel 80 µm; D left panel 500 µm; right panel 100 µm; E 2000µm; F-G 
1000µm. 
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Fig. 2.2 Knocking out Lats1/2 leads to coronary vessel defects. (A) Coronary 
vessels were visualized by PECAM-1 whole-mount staining at E14.5. Lats1/2 
CKO hearts exhibited decreased vessel coverage (arrows) and disorganized 
vessel patterning (asterisks) on ventral and lateral side of the heart. (B) PECAM-
1 immunofluorescent whole-mount staining. Lats1/2 CKO exhibited malformed 
coronary vessel patterning. (C) Quantitative analysis of vasculature in B (n=3 in 
each group). Data shown are means ± SD. p<0.1 was by Mann-Whitney U test. A 
500µm; B upper panels 200µm, bottom panels 100µm. RV: right ventricle; LV: left 
ventricle;  
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To exclude the possibility that Wt1CreERT2 heterozygosity contributed to the 
vascular phenotype, we injected tamoxifen to Wt1CreERT2 /+ embryos and Cre 
negative littermates to compare the coronary vessel phenotype. As another 
control, we injected vehicle (peanut oil) to Wt1CreERT2; Lats1/2 f/f and their Cre 
negative littermates to compare coronary vessel phenotype. In both of these 
controls, coronary vessel development was normal (Fig. 2.3 A,B).  
 
 
 
 
Figure 2.3. Control experiments to validate coronary vessel development 
defects in Lats1/2 CKO.(A)Wt1 CreERT2/+; Rosa26 mTmG injected with Tamoxifen 
(TAM) exhibited well-formed coronary vasculature compared with Rosa26 mTmG 
littermate at E14.5. (B) Wt1 CreERT2/+; Lats1/2 f/f hearts exhibited organized coronary 
vessel injected with vehicle control peanut oil compared with Lats1/2 f/f littermate 
at E15.0. Scale bar: 400µm. 
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Next, we examined Yap sub-cellular localization and Yap phosphorylation 
(p-Yap) and as a readout of Lats kinase activity in Lats1/2 CKO and control 
embryos. Yap localization in Lats1/2 CKO hearts, detected by total Yap IF and co-
labeling with podoplanin, revealed increased nuclear Yap in both epicardium and 
subepicardium of Lats1/2 CKO hearts (Fig. 2.4 A-B). p-Yap IF revealed decreased 
p-Yap in Lats1/2 CKO epicardium and subepicardium as compared to control 
hearts (Fig. 2.4 C). We noted that podoplanin, while restricted to the epicardium 
in control embryos, was also expressed in subepicardium in Lats1/2 CKO 
embryos suggesting that EMT occurred prior to repression of epicardial gene 
program (Fig.2.4C). To determine if Yap function was required for the Lats1/2 
CKO mutant vascular phenotype, we performed a genetic suppression 
experiment by genetically reducing endogenous Yap and Taz levels in Lats1/2 
CKO embryos. We generated Wt1CreERT2; Lats1/2f/f; Yap/Taz f/+ embryos and 
induced Cre activity at E11.5. All compound mutant embryos were viable at E15.5, 
although the herniated liver and intestinal phenotypes persisted (data not shown). 
The morphology of Wt1CreERT2; Lats1/2f/f; Yap/Taz f/+ hearts appeared to be similar 
to the Cre negative littermate controls, with no evidence of major coronary 
vasculature defects (Fig. 2.4 D-E).  
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Figure 2.4. Reducing Yap/Taz activity rescues the phenotype resulted from 
Lats1/2 deficiency.(A) Podoplanin labels the epicardium and Lats1/2 CKO hearts 
show increased nuclear Yap localization in the epicardium (white arrows) and 
subepicardium(yellow arrows). (B) Quantification of Yap cellular localization. Data 
shown are means ± SD. p<0.1 Nuclear Yap percentage (%) was by Mann-Whitney 
U test. (C) Phosphorylation status of YAP (p-YAP) is a direct readout for Lats1/2 
activity. Lats1/2 CKO showed decreased p-Yap in epicardium (white arrows) and 
subepicardial region (yellow arrows). (D-E) Lats1/2 CKO hearts with reduced 
Yap/Taz activity appeared to be normal at E15.5 compared to their littermate 
controls. A 25µm; C 25µm, D 400µm,E 200µm. Scale bar: LA: left atrium; RA: 
right atrium; LV: left ventricle; IVS: interventricular septum. RV: right ventricle; LV: 
left ventricle; N: Nuclear Yap; N/C Nuclear/Cytoplasmic Yap; C: Cytoplasmic Yap; 
Epi: epicardium; Myo: myocardium.  
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Recent work indicated that deletion of Yap and its paralog Taz in the 
epicardium led to defective EMT and reduction of epicardial-derived lineages (27). 
We performed in situ hybridization to examine EMT marker expression. 
Expression of a canonical EMT regulator, the gene encoding the zinc finger 
transcription factor Snai2 was elevated in the mutant hearts, while another EMT 
marker,Twist1, was unchanged (Fig.2.5). These results suggest that Lats1/2 
kinases are required for normal coronary vessel development by restricting 
epicardial and subepicardial Yap activity.  
 
 
 
 
 
Figure 2.5 EMT factors expression in epicardium and EPDC. EMT factors 
Twist1 and Snai2 detected by in situ probe at E14.5. Scale bar: 25 µm. 
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Unbiased single-cell transcriptome profiling of embryonic cardiac tissue at 
E13.5 and E14.5 
To simultaneously capture the cellular states of all cardiac cell types in 
control and Lats1/2 mutants, we performed Drop-seq to profile cardiac tissue from 
control and Lats1/2 CKO embryos at E13.5 and E14.5, the stages preceding 
Lats1/2 CKO embryonic lethality. Graph based clustering was performed on 
significant principle components and the results visualized through the non-linear 
dimensional reduction algorithm, t-Disributed Stochastic Neighbor Embedding 
(tSNE) (8,17,28-30). Embedding 18,166 single cells across two time points and 
two genotypes into the final projection that revealed 28 distinct clusters (Fig. 2.6 
A,B). Differential expression analysis on spatially proximal clusters was carried 
out to identify transcriptionally well-defined clusters. Clusters without appreciable 
transcriptional distinctions were merged and classified based on the expression 
of known markers (Fig. 2.6 C).  
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Figure 2.6. High-throughput single cell RNA-seq of wild type and Lats1/2 
CKO embryonic cardiac tissue. (A) two-dimensional tSNE representation of 
18,757 single-cell transcriptomes colored by experimental group. (B) tSNE 
visualization of graph-based clustering carried out on the comprehensive 
embryonic mutant and non-mutant dataset. (C) Classification and merging of 
clusters shown in Figure 2B. Red blood cells and platelets, cluster 16, are 
removed. 
 
 
 
 
The main cardiac cell types, including cardiomyocytes, endothelial cells, 
smooth muscle cells, mesenchymal cells, macrophages, and epicardial cells had 
cluster sizes in the range of 63 to 4,716 cells (Fig. 2.7 B). We first evaluated non-
epicardial-derived lineage, specifically cardiomyocytes and endothelial cells.  A 
comprehensive analysis of E13.5-E14.5 heart tissue, excluding the atria, revealed 
a cellular composition that is distinct from adult murine cardiac tissue (Fig. 2.7 B). 
Adult cardiac tissue is made up of approximately 31% cardiomyocytes and 43% 
endothelial cells (Pinto et al., 2016). Our results indicated that the E13.5-E14.5 
murine heart contains 43% cardiomyocytes and only 19% endothelial cells. 
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Figure 2.7. Cell type composition of wild type and Lats1/2 CKO embryonic 
cardiac tissue at E13.5 and E14.5. (A) Heatmap of differentially expressed 
genes (rows) across the final 18,166 cells (columns). (B) Sunburst plot of E13.5-
E14.5 cardiac cell composition as determined by Drop-seq.  
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Importantly, these cardiac cell types displayed considerable heterogeneity 
and were further sub-categorized (Fig. 2.8). Within the cardiomyocyte lineage, the 
two rarest cardiomyocyte populations were atrioventricular canal (AVC) and 
trabecular cardiomyocytes. AVC cardiomyocytes were identified based on a 
molecular signature that included the Wnt-pathway gene Rspo3 and the Bmp-
pathway gene Bmp2 (Fig. 2.8, Fig. 2.9) (Cambier et al., 2014). Trabecular 
cardiomyocytes were identified by a signature that included Nppa and Gja5 (Fig. 
2.8, Fig. 2.9)(Jensen et al., 2012). In addition to Bmp2, we detected several other 
AVC cardiomyocyte markers, including Pitx2, Shox2, Wisp1, Tbx2, Tbx3, Tbx5, 
and Bmp7 (Campione et al., 2001; Habets et al., 2002) (Fig. 2.9). Further 
clustering revealed several known and novel cardiomyocyte markers, as well as, 
transcriptional signatures of proliferating cardiomyocytes (Fig. 2.9) (Li et al., 
2016). 
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Figure 2.8 Lats1/2 CKO and wild type (WT) single-cell composition for 
individual cluster categories. Phylogenetic tree showing the relationship of 
each identified cell type based on 3,217 appreciably expressed genes with high 
dispersion (> 2 standard deviations above average dispersion) (left). Dot plot 
showing the relative proportion of cells belonging to each genotype across E13.5 
and E14.5 time points colored according to Figure 2A. The size of the dots 
represents the percentage of cells within each identity class. Numbers on the dots 
are the actual cell numbers in the corresponding cluster and the numbers below 
each genotype are the total cell numbers we analyzed in each experimental group 
(middle, Chi-squared analysis, * p-value < 0.0025). Violin plot of gene expression 
for representative markers of each categorical class colored according to Figure 
2.6C(right). 
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Figure 2.9 Cardiomyocyte subclusters at E14.5. Heatmap of top differentially 
expressed genes among rare cardiomyocyte cell populations. Highly expressed 
genes are shown as yellow/orange. 
 
 
 
Endothelial cells, well represented in our data set, comprised a total of 5 
clusters. Arterial endothelial cells were distinguished by several markers, 
including Gja5, Fbln2, Fbln5, and Sox17 (Fig. 2.7B, Fig.2.8 and Fig. 2.10) (Liu et 
al., 2015). Vascular endothelial cells were clearly distinguishable by Fabp4 and 
Apln expression (Fig. 2.10) (He et al., 2014; Liu et al., 2015). Endocardial cells 
were characterized by high level of Npr3 (Zhang et al., 2016) in addition to other, 
previously unknown markers including Ednrb, Adgrg6, Plvap, and Smoc1 (Fig. 
2.10). This comprehensive and novel characterization of endothelial cell 
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heterogeneity in the developing heart may reflect the distinct cellular origins of 
endothelial cells and their unique functions although this possibility will require 
further investigation. 
  
 
 
 
Figure 2.10 Endothelial cell subclusters at E14.5. Heatmap displaying the top 
differentially expressed genes across all endothelial-like cells. Highly expressed 
genes are yellow. 
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Our data revealed several cell types with critical roles in valve 
development. We performed graph base clustering and tSNE visualization of the 
valve data subset (Fig. 2.1G and Fig. 2.2D) including Scx-positive valve 
mesenchymal cells, Twist1-positive atrioventricular valve and cushion cells, 
Bmp2-positive AVC cardiomyocytes, and Nfatc1-positive valve endocardial cells 
(Fig. 2.1F) (Chakraborty et al., 2008; Gong et al., 2014; Katz et al., 2012; Ma et 
al., 2005; Wu et al., 2011). We found AV cushion mesenchymal cells expressed 
Wnt-pathway genes Lef1 and Tbx20 while valve mesenchyme expressed Sfrp2 
and Dkk3 (Fig. 2.1 H, Fig. 2.2 D) (Cai et al., 2013).  
Interestingly, we discovered three distinct clusters of Nfatc1 positive cells 
(EndoV1-EndoV3) revealing a previously unappreciated heterogeneity within the 
valvular endocardium, including the EndoV3 cluster that displayed high 
expression of endocardial-to-mesenchymal transition (EMT) associated genes 
Enpp2, Prox1, and Fzd10 (Fig. 2.1 G,H) (Gong et al., 2014; Lu et al., 2012; Shaul 
et al., 2014). The heterogeneity of valve endocardial cells may be the result of 
dynamic cellular phenotypic changes during EMT. We also noted heterogeneous 
expression across these endocardial valve clusters of different aquaporin (AQPs) 
family genes (e.g. Aqp8 and Aqp1). AQP genes, encoding water channel proteins 
controlling cellular osmotic balance, have not previously been implicated in valve 
endocardial development (Fig. 2.2 C, D). Due to their potential roles in osmotic 
stress, for example after ischemia-reperfusion (Au et al., 2004), AQPs may be 
interesting targets for future studies.  
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Figure 2.11. Clustering and tSNE visualization of 4,183 cells implicated in 
valvulogenesis.  
 
 
 
 
Figure 2.12. Single-cell markers of cardiac valve development. The relative 
expression levels of each gene (column) are shown as dots for each of the 6 
cardiac valve clusters identified in Figure 2.8. 
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Figure 2.13 Feature expression plots of the classic, as well as some novel 
genes expressed during valvulogenesis. Gene expression is indicated by dark 
black, and the background color indicates the cluster/cellular identity shown in 
Figure 2.11. 
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Identification of an epicardial-derived cell population composed primarily of 
Lats1/2 deficient cells  
 To investigate the molecular changes resulting from loss of epicardial 
Lats1/2 kinase function, we compared the relative proportions of each cell type 
between control and Lats1/2 mutant hearts (Fig. 2.8). Although we saw 
differences in a few non-epicardial-derived cell types, such as macrophages and 
trabeculated myocardium, for this study we focused our attention on the epicardial 
lineage. Two clusters showed statistically significant enrichment of Lats1/2 mutant 
cells compared to control (chi-squared test, p < 0.0025). One of these was the 
epicardial cluster, which suggests increased proliferation and self-renewal or 
defective differentiation of the Lats1/2 mutant epicardium. The second 
predominantly mutant cluster, designated as Cluster 20 (C20), possessed a gene 
signature intermediate between that of fibroblasts and epicardium. C20 cells 
expressed Tcf21, a gene encoding a basic helix loop helix transcription factor 
whose expression demarcates epicardial cells committed to the cardiac fibroblast 
lineage and resting cardiac fibroblasts (Fig. 2.8) (31).  We also observed a 
reduction in the number of cardiac fibroblasts in E14.5 mutant hearts, suggesting 
a defect in epicardial to fibroblast transition (Fig. 2.8). There was no difference in 
the smooth muscle lineage, the other major EPDC-derived cell type, between 
control and Lats1/2 mutant hearts (Fig. 2.8).   
To further determine the transcriptional distinctions between C20, 
epicardial cells, and cardiac fibroblasts, we performed iterative clustering. We 
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included vascular endothelial cells (VECs) in our analysis given the defective 
coronary vessel phenotype. Cell barcodes were selected from each cell type and 
deposited into a new digital expression matrix prior to principle component 
analysis (PCA), graph based clustering, and tSNE visualization. We evaluated 
these cell types and performed differential expression analysis (likelihood-ratio 
test for single cell gene expression (18) (Fig. 2.14). In addition to the original four 
clusters, iterative clustering identified a clearly distinguishable fibroblast-like sub-
type, FB2, which closely resembles pericytes as it is positive for Mcam, Cspg4 
(Ng2), and Pdgfrb (Fig. 2.15). 
 
 
 
 
 
Figure 2.14. Subsetting and clustering of epicardial and putative epicardial-
derived cells. (A)(Right) View of experimental identity for each single-cell in the 
data, colored as in Fig. 2.6A. (B) tSNE plot of Lats1/2 CKO enriched clusters. 
Epicardial cells (EPI), fibroblasts (FB), cluster number 20 (C20), vascular 
endothelial cells (VEC), and fibroblast cluster 2 (FB2) which resemble pericytes. 
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Figure 2.15. Heatmap of differentially expressed genes from FB, VEC, EPI, 
C20, and FB2 clusters. Rows are genes and columns represent single-cells. Red 
indicates high relative expression. 
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The C20 transcriptional signature resembled that of fibroblasts, while 
sharing epicardial features, but it was distinct from VECs (Fig. 2.15). C20 cells 
expressed a subset of fibroblast markers such as Col1a1 and Spon2, yet was 
deficient for mature fibroblasts markers, such as Postn and Sox9 (Fig. 2.15, 
Fig.2.16). C20 cells also expressed epicardial genes such as Wt1 and Aldh1a2, 
as well as, Dpp4, Smoc2, and Alcam, but failed to express other mesothelial 
markers such as Upk3a and Upk3b, encoding integral membrane proteins (Fig. 
2.15). Other genes that were not normally expressed in epicardium or fibroblasts 
were uniquely enriched in C20, such as Ephb2 and Vgll3, indicating that C20 
possesses its own distinctive signature, while sharing similarity with the 
epicardium and cardiac fibroblasts. Overall, the Drop-seq data showed 
accumulation of epicardial progenitor cells and C20 cells, with a concomitant 
reduction in differentiated cardiac fibroblasts in Lats 1/2 mutant hearts. This 
suggests that Lats1/2 is required for progression of epicardium to a fibroblast fate.  
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Figure 2.16. Gene expression projected across the tSNE. Black indicates high 
gene expression, and cluster identities and boundaries are set in the background 
and colored according to Figure 2.14B. 
 
 
 
 
 
 
Pseudo-time analysis reveals that Lats1/2 deficiency results in defective 
epicardial cell developmental transitions  
 Our data suggest that Lats1/2 deficiency perturbed the normal epicardial 
developmental trajectory. To look at this question more carefully, we used the 
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Monocle2 algorithm to order cells along a developmental axis progressing from 
epicardial cells to cardiac fibroblasts (19). Importantly, the pseudo-time ordering 
matched closely with the graph-based clustering results, especially when 
projected across the tSNE (Fig. 2.3E,F). The left most portion of the epicardial 
cluster represents the most primitive cellular-state, while the bottom right section 
represents the most differentiated cellular state (Fig. 2.3E, bottom panel). C20 is 
isolated centrally along this differentiation axis supporting the notion that C20 is a 
transition state intermediate between epicardial progenitors and differentiated 
fibroblasts (Fig. 2.3E, top panel).  
Cells diverging from the Monocle Minimum Spanning Tree (MST) are 
captured as alternative trajectories by their connection to the full MST path 
through a node (32). Nodes represent potential developmental junctions where 
cell-fate decisions are made. We identified a node (Fig. 2.3E, bottom, Node X) 
proximal to the final bifurcation of cardiac fibroblasts (Fig. 2.3E, Branch A) and the 
C20 population (Fig. 2.3E, Branch B) revealing two distinct EPDC differentiation 
paths. The “Branch A” trace, composed primarily of control cells, revealed the 
normal EPDC to fibroblast  differentiation trajectory and the cellular transition from 
epicardium to mature fibroblast. In contrast, the “Branch B” trace, comprised 
predominantly of Lats1/2 mutant cells, revealed an intermediate epicardial-
fibroblast cell type, indicating that these Lats1/2 mutant cells failed to progress to 
a fully differentiated cardiac fibroblast.  
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Figure 2.17. Pseudotime trajectory of epicardial cells, fibroblasts, and C20. 
Cells are colored by cluster across the epicardial to fibroblast differentiation 
axis(top). The pseudotime score is assigned to individual cells. Cells with a dark 
color and bright color represent the start and end of pseudotime respectively 
(bottom). The Monocle2 minimum spanning tree is the underlying black line, and 
the critical node is denoted as ‘X’ with dashed arrows representing the bifurcation 
of Branch A (fibroblast) and Branch B (C20).   
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To identify the genes associated with the Node X bifurcation, we examined 
gene expression patterns across pseudotime and uncovered several co-varying 
expression patterns. The first expression pattern, attributed to fibroblast 
differentiation, had a relatively higher expression level in differentiated fibroblasts 
(Fig. 2.18 A(B)). We focused on the genes associated with Branch B, and 
performed gene ontology (GO) analysis (Fig. 2.18 A(B) shading to Fig. 2.18 B).  
The enriched GO terms included extracellular matrix and vascular 
morphogenesis, suggesting that C20 contributed to the coronary vessel 
remodeling defects observed in Lats1/2 CKO hearts (Fig. 2.18 B). Further, the 
enriched GO term, regulation of cell migration, included several genes that have 
been shown to promote EMT, such as Bmp4, Edn1 and Ptn (Fig.2.18B)(33-35) 
further supporting the idea that C20 cells efficiently progressed through EMT. This 
also agrees with the observation that the EMT marker, Snai2, was elevated in 
Lats1/2 CKO embryos (Fig.2.19).  
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Figure 2.18. Gene expression pattern associated with pseudotime. (A) 
Hierarchical clustering of genes with branch-specific trends in gene expression 
across pseudotime. (top three: gene expression pattern enriched in Branch A; 
bottom three: gene expression pattern enriched in Branch B). (B) Gene ontology 
(GO) analysis of the genes identified from branch B, C20-specific, in Branch A. 
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Figure 2.19. EMT factors expression in epicardium and EPDC. EMT factors 
Twist1 and Snai2 detected by in situ probe at E14.5. Scale bar: 25 µm. 
 
 
 
 
The majority of Cluster 20-enriched genes are direct Yap-Tead targets 
To identify the upstream regulators of C20 enriched genes, we performed 
transcription factor DNA-binding motif enrichment analysis across a 20 kb region 
centered on the Transcription Start Site (TSS) of each Branch B gene. Srf and 
Tead elements were the most enriched motifs in the Branch B gene set. While 
Tead was highly expressed in C20, Srf was present at low levels in C20, 
suggesting that most Branch B genes were directly regulated by Yap-Tead (Fig. 
2.20A). Indeed, Tead1 expression is enriched throughout C20 and its relative 
expression level decreases sharply moving across pseudotime from C20 toward 
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fibroblasts (Fig. 2.20B). Conversely, Sox9 is low in epicardial and C20 cells but 
high in cardiac fibroblasts (Fig. 2.20B). Finally, we identified Tead1 motif enriched 
genes present in Branch B, and performed GO analysis specifically on these Yap-
Tead target genes. We found several GO terms that were particularly well-
represented among Branch B-specific Yap-Tead targets, including extracellular 
matrix organization, regulation of cell migration, and blood vessel development 
(Fig.2.18B, Fig. 2.20C). Additionally, we also uncovered other genes such as 
Dhrs3, not included in a specific GO category, that also are Yap-Tead target 
genes contained in C20 cluster (Fig. 2.20C). 
 
 
 
Figure 2.20. Cluster 20-enriched genes are direct Yap-Tead targets. (A)Motif enrichment 
analysis of Branch B, C20, specific genes. Expression of each transcription factor is in percent of 
cells above threshold within C20. Red indicates high expression. (B) Expression and cell density 
plots of key transcriptional regulators across pseudotime. Points are each colored by cluster 
identity from Figure 2.14 B, and 2.17A. (C) Tead1 target gene visualization and annotation. Gene 
ontology categories assigned and color coordinated based on Figure 2.18B. 
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The C20 cluster resides in subepicardium and Lats1/2 deficiency results in 
subepicardial expansion 
To validate our findings from pseudo time analysis and gain spatial 
information about C20, we performed IF experiments based on known epicardial-
associated markers and newly identified genes expressed in C20. Expression of 
α-actinin outlined the division between myocardium and 
epicardium/subepicardium (Fig. 2.21 A,B).  We investigated podoplanin 
expression, a marker of the single cell layer epicardium in control hearts and 
Lats1/2 CKO hearts. As mentioned above, podoplanin expression expanded into 
subepicardium suggesting that the Lats1/2 CKO mutant subepicardium still 
maintained some epicardial characteristics (Fig. 2.21 A,B).  
We next investigated Pdgfrα expression, as it marks fibroblasts and the 
subepicardium. In control hearts, Pdgfrα was expressed in a single cell layer 
within subepicardium, while in Lats1/2 CKO embryos Pdgfrα was expressed in a 
several layer thick subepicardium (Fig. 2.21 C, D). Likewise, Wt1, a marker for 
epicardium and subepicardium, was expressed in Lats1/2 CKO epicardium and 
the expanded subepicardium (Fig. 2.21 E) (36). Similarly, Dpp4 and Col1a1, 
expressed in both epicardium and subepicardium, were expressed in epicardium 
and expanded subepicardium in Lats1/2 CKO hearts (Fig. 2.21 F). Together, the 
IF data support the conclusion that the C20 population normally resides in 
subepicardium and that Lats1/2 deficiency results in subepicardial  expansion. 
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Figure 2.21. C20 is located in the subepicardium and expands in Lats1/2 CKO hearts.(A-B) Podoplanin labels 
epicardium (white arrows) and α -actinin labels myocardium. The region in between of podoplanin and α -actinin delineated 
the subepicardium in control hearts. The expanded subepicardium in Lats1/2 CKO were weakly stained by  podoplanin 
(yellow arrows in Lats1/2 CKO). Data in Fig.4B are means ± SD. *P<0.1 was by Mann-Whitney U test. (C-D) PDGFR-α 
rarely labels epicardium(white arrows) and extensively labels subepicardium (yellow arrows). Lats1/2 CKO hearts exhibited 
thickened PDGFR-α positive subepicardium. (E) Wt1 labels epicardium (white arrows) and subepicardium (yellow arrows) 
in Lats1/2 CKO hearts. Lats1/2 CKO hearts displayed expanded Wt1 positive subepicardium. (F) Dpp4 labels epicardium 
(white arrows) and subepicardium (yellow arrows). Lats1/2 CKO hearts displayed expanded Dpp4 positive subepicardium.  
(G-H) Collagen I labels epicardium (white arrows) and subepicardium (yellow arrows). Lats1/2 CKO hearts showed 
expanded Collagen I positive subepicardium.  Data shown are means ± SD. *P<0.1 was by Mann-Whitney U test. 
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Lats1/2 epicardial deficiency results in diminished cardiac fibroblast 
differentiation  
               Next, we investigated the cardiac fibroblast differentiation defect in more 
depth by performing lineage-tracing experiments using the Rosa26mTmG genetic 
reporter to follow epicardial-derived lineages. EdU labeling indicated that in 
Lats1/2 CKO embryos the Wt1CreERT2 lineage-derived epicardial cells and EPDCs 
were more proliferative than controls (Fig. 2.22 A-C). We noted that proliferation 
genes were not enriched on the Branch B GO analysis suggesting that 
proliferation was not the only distinguishing factor between C20 and cardiac 
fibroblasts (Fig. 2.18 B). Using the Rosa26mTmG genetic reporter to label the 
Wt1CreERT2 lineage and PDGFRα to mark cardiac fibroblasts, we observed by IF 
and FACS a reduction in epicardial-derived fibroblasts from 44% to 32% in Lats1/2 
CKO mutants compared to controls (Fig. 2.23 A-C). IF, using another fibroblast 
marker Vimentin, further confirmed the reduction of epicardial-derived fibroblasts 
(Fig. 2.23 D-E). Taken together, the lineage tracing data further corroborated our 
previous Drop-seq results, demonstrating that inactivation of Lats1/2 led to 
defective epicardial differentiation into mature cardiac fibroblasts.   
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Figure 2.22. Increased epicardium and EPDC proliferation in 
Lats1/2 CKO hearts. (A) The Wt1 lineage was traced by GFP 
expression, which includes epicardium and EPDC.  An increased 
number of epicardium and EPDCs were observed in Lats1/2 CKO 
hearts. (B-C) Lats1/2 CKO exhibited significantly increased EdU 
labelling in GFP positive cells. Proliferating epicardial cells and EPDC 
were indicated as GFP+ EdU+ double positive cells(arrowheads). 
*P<0.05, Mann-Whitney U test. Data shown are means ± SD. Scale 
bar: 50µm.  
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Figure 2.23. Knocking out Lats1/2 in epicardium leads to reduction of epicardial derived fibroblast. 
(A-B) The epicardial lineage was traced by GFP expression. Epicardial-derived fibroblasts are labelled 
(arrowheads) by GFP and PDGFR-α double positive staining. Other epicardial-derived lineages are indicated 
(arrows) by GFP single positive staining. A reduction of epicardial derived fibroblasts were observed in 
Lats1/2 CKO hearts. Panels on the left are a higher magnification view of the boxed area in the panels on 
the right. (B-C) FACS analysis quantification of the percentage of epicardial derived fibroblasts (*P<0.0001 
was by Chi-square test). (D-E) Another fibroblast marker Vimentin also showed decreased epicardial derived 
fibroblasts in Lats1/2 CKO hearts (epicardial derived fibroblasts: arrowheads, epicardial derived other 
lineages: arrows). Panels on the left are the higher magnification of the boxed area in the panels on the right. 
Data shown are means ± SD. *P<0.1, Mann-Whitney U test. Scale bar: 50µm.  
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Yap controls fibroblast differentiation and coronary vessel patterning 
 
Motif analysis showed enrichment of Tead motifs in C20-expressed genes 
(Fig. 2.20 A).  Moreover, our genetic rescue experiment supported the conclusion 
that coronary vessel defects are mediated through Yap (Fig. 2.4). Next, we 
analyzed the TEAD motif-containing cis-regulatory regions in genes revealed by 
Drop-seq.  
             Several secreted intercellular factors associated with vascular 
morphogenesis were enriched in C20 including Spon2, Ogn, Dpp4, Gpc3 and 
Alcam (Fig. 2.15, Fig.2.16), all of which have been suggested to regulate 
vasculogenesis and angiogenesis (26,37-41). Dhrs3, as shown above, was up-
regulated in the differentiation arrested Branch B (Fig. 2.20), which may contribute 
to impaired epicardial-fibroblast differentiation by reducing retinoic acid signaling  
(42). To determine if the C20- expressed genes are directly regulated by Yap, we 
compared embryonic heart H3K27ac data with cardiac DNase-seq (DNase I 
hypersensitive site (DHS)) data and extracted TEAD motifs from the E14.5 
H3K27ac peaks. Several consensus TEAD motifs, Yap binding sites, were 
identified at enhancer and promoter regions of genes enriched in Branch B, such 
as Ogn, Spon2, Gpc3, and Alcam (Fig. 2.24 A,B). Consensus Tead motifs were 
also found in Dpp4 and Dhrs3. We further validated Yap-Tead regulation of Dpp4 
and Dhrs3 by performing Yap ChIP-qPCR at the Tead motifs contained within 
H3K27ac and DHS peaks to determine if Yap directly bound to these loci. In both 
Dpp4 and Dhrs3, Yap showed specific binding further supporting the notion that 
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Yap directly regulates genes that are essential for normal coronary vessel 
patterning and cardiac fibroblast differentiation (Fig.2.24 C). 
 
 
 
Figure 2.24. Direct Yap binding to the regulatory regions of the factors 
regulating extracellular milieu and cell differentiation in Lats1/2 CKO hearts. 
(A) Numerous TEAD binding motifs were identified at the regulatory regions of 
genes encoding intercellular factors. (B-C) Yap-TEAD binding sites locates at the 
regulatory regions of Dpp4 and Dhrs3. Yap ChIP-qPCR, quantified in the bar 
graphs, demonstrated Yap binding at the yellow highlighted region in the 
corresponding gene tracks. Data are means ± SD. *P<0.1 was by Mann-Whitney 
U test. 
 
 
45 
 
 
 
Discussion 
Our study used high-throughput sc-RNA-seq to uncover an essential role 
of Lats1/2 in orchestrating epicardial lineage differentiation into cardiac 
fibroblasts. Lats1/2 kinases function to restrain Yap transcriptional activity and 
regulate the transition from epicardium to subepicardial mesenchyme and mature 
cardiac fibroblasts. In addition, Lats1/2 function is required for a precise 
extracellular milieu to enhance coronary vascular development (Fig. 7). Our data 
provide new insight into cardiac cellular diversity at two different developmental 
stages, E13.5 and E14.5.  
 
 
 
 
Figure 2.25. Working model. Lats kinase regulation of subepicardial cell 
differentiation to cardiac fibroblasts and coronary vessel patterning through 
controlling the composition of the extracellular milieu.  
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Using Drop-seq, we investigated cardiac cellular diversity during 
development at E13.5-14.5. Our data provide important insight into all major 
cardiac cell types, including rare cell types like macrophages and arterial 
endothelial cells. Interestingly, we also uncovered the transcriptional signatures 
of proliferating cardiomyocytes that will be useful for further studies in 
cardiomyocyte development and regeneration. Furthermore, we characterized 
many cell types that are required for valve development and we identified novel 
markers for cells that contribute to developing valves. Interestingly, distinctions 
between left and right ventricular cardiomyocytes identified by Li et. al at E10.5 
were not appreciable in our data set, suggesting that these transcriptional 
distinctions are negligibly by E13.5 (43). It is likely that by E13.5 cardiomyocytes 
derived from both heart fields have differentiated to an extent that their molecular 
signatures become indistinguishable. Consistent with Li et. al, we detected 
signatures for AVC and trabecular cardiomyocytes. 
Lats1/2 regulate epicardial progenitor differentiation into cardiac fibroblasts 
By examining the relative proportion of cells from wild type and Lats 1/2 
mutant heart within each cluster, we found that epicardium and C20 are composed 
predominantly of Lats1/2 mutant cells. C20, a cell type intermediate between 
epicardium and fibroblast is located in subepicardium. The characteristics of C20 
indicate that in Lats1/2 mutants there is a defect in the epicardial-to-cardiac 
fibroblast developmental trajectory. Consequently, we observed that the 
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epicardial-derived fibroblast cluster at E14.5 is reduced in Lats1/2 mutant hearts. 
However, we did not find any differences in smooth muscle cells, the other major 
epicardial derivative, revealing a specific role for Lats1/2 function in fibroblast 
differentiation.  
Lats1/2 CKO hearts displayed subepicardial expansion and reduction of 
epicardial derived fibroblasts. Indeed, Lats kinases are inhibitors of cell 
proliferation and Lats1/2 deficient subepicardium showed increased EdU 
incorporation, suggesting that up-regulated proliferation within this region 
contributed to the accumulation of C20 cells in subepicardium. Nonetheless, our 
pseudotime and sc-RNA-seq data provided the resolution to show that 
proliferation was not the major difference between C20 and cardiac fibroblasts. 
Rather, we identified Yap target genes such as Dhrs3 that possibly inhibit 
fibroblast differentiation directly by down-regulating retinoic acid signaling.  
Recent work showed that Yap/Taz in the AVC and epicardium is required 
for  EMT (44), and in the epicardial context, led to subsequent decrease of all 
epicardial-derived lineages (27). In our study, excessive nuclear Yap activity in 
Lats1/2 CKO did promote EMT supporting the role for Yap as an inducer of EMT. 
In contrast, we do not detect a smooth muscle phenotype in Lats1/2 CKO 
suggesting that Yap/Taz are regulated through both Hippo-dependent and Hippo-
independent mechanisms in epicardial development (45).  
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Hippo signaling coordinates vascular development with fibroblast 
differentiation  
                An important insight from our study, not previously appreciated, is the 
essential non-autonomous connection between cardiac fibroblast differentiation 
and vascular patterning. Our data suggest that the disorganized coronary vessel 
patterning in Lats1/2 CKO hearts is due to aberrant signaling from Lats1/2 mutant 
C20 cells.  Cross talk mediated by growth factors between epicardium and 
myocardium is critical for coronary vessel angiogenesis and myocardium growth 
during heart development (46,47). Our data show that developing fibroblasts 
express growth factors and factors that modulate extracellular matrix composition 
that controls signaling to the developing vasculature. 
The genes enriched in C20 cells (Branch B, Fig. 3E) indicate that 
extracellular matrix organization and growth factor binding was disrupted in Lats 
1/2  mutant hearts. Several intercellular factors such as Smoc2, Spon2 and Ogn 
are proteins embedded in the extracellular matrix that modulate growth factor 
activity to control angiogenesis. In addition to extracellular proteins, the cell 
surface serine protease, Dpp4, and its direct inhibitor Gpc3 regulate multiple, 
essential signaling events in coronary vascular development (39,48). Dpp4 
controls the functional activity of chemokines and cytokines that contain Dpp4 
proteolytic motifs including members of the FGF, BMP/TGF β, IGF, CXCL, and 
CCL family. Importantly, many of these signaling factors have been implicated in 
coronary vasculature development (26,38,40). Multiple TEAD motif were found in 
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the regulatory regions of these genes suggesting that they are direct Yap target 
genes. In particular, Dpp4 was validated as a direct target of Yap. These data are 
consistent with our genetic evidence showing that reduced Yap/Taz dosage in 
Lats1/2 mutant epicardium suppressed the vascular phenotype of Lats 1/2 CKO 
hearts.  
During normal heart development, organ vascularization is coordinated 
with overall heart size to meet the growing metabolic needs of the heart. Our data 
suggest that the epicardium and subepicardium are important for coordinating 
organ vascularity with organ size. In other contexts, it has been shown that in 
addition to Hippo pathway kinases, mechanical tension acts as another mode of 
regulation of nuclear Yap activity (49). Thus, a tempting model would be that an 
increase in tissue surface tension gradually activates Yap in 
epicardium/subepicardium as heart size increases. With heart growth, a gradual 
tension increase on epicardium and subepicardium may transiently promote 
nuclear Yap activity and EMT with subepicardial cell proliferation. In this scenario, 
Hippo kinase activity may modify the influence of mechanical tension on EMT and 
proliferation so that the correct number of subepicardial cells are formed.  
Within subepicardial cells, Lats1/2 kinases are important for enhancing 
differentiation into cardiac fibroblast. In addition, our study suggested that 
subepicardial cells provide a permissive extracellular matrix environment that is 
essential for coronary vascular development and maturation. The subepicardium, 
a transient and rare population, is difficult to study. In Lats1/2 mutants this 
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population is expanded and by performing transcriptomics at single cell resolution, 
we were able to study this population in greater depth. Our findings suggest that 
as endothelial progenitors invade the heart they require an ECM provided by 
subepicardial cells to develop normally.    
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CHAPTER III  
 HIPPO AND MECHANICAL SIGNALING COOPERATIVELY DETERMINE 
EPICARDIAL CELL SPECIFICATION 
Introduction 
Coronary artery disease is a major cause of heart failure and death 
worldwide (7,50). It is imperative to identify effective therapies to restore coronary 
circulation and heart function. Recent findings indicated that adult epicardium and 
epicardial derived cells (EPDCs) reexpress embryonic genes, resume embryonic 
plasticity, and facilitate cardiovascular repair following injury (46,51-53). 
Understanding the molecular mechanisms regulating epicardial development 
would be expected to offer new therapeutic targets for cardiac repair after injury. 
In mammals, EPDC derived from Wt1 expressing lineage mainly give rise 
to vascular smooth muscle cells and fibroblasts. A second epicardial lineage, 
expressing Scx and Sema3D contribute to endothelial cells (54). A small 
percentage of epicardial cells are positive for both Wt1 and Scx and Sema3D (54). 
In addition to its cellular contribution, EPDC secrete growth factors that promote 
vasculogenesis and angiogenesis and enhance cardiomyocyte proliferation (51).  
Mechanical signaling and cell shape changes, driven by mechanical forces, 
influence cell fate determination in cultured cells (55,56). In mechanical signaling, 
the cell transduces extracellular mechanical cues into a biochemical output. The 
activity of Hippo pathway components Mst1/2, Lats1/2, and Yap both influence 
and are influenced by cytoskeletal organization that adjusts to mechanical input 
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from external forces (57). For example, cells grown on hard substrates or low 
density have more F-actin polymerization with preferentially nuclear localized 
Yap. In contrast, soft substrates or high cell density reduces F-actin 
polymerization and sequesters p-Yap in the cytoplasm. The mechanical cues 
inducing Yap translocation or activation/inactivation have been proposed to be 
both Lats1/2 dependent and independent (49,58). However, in the epicardium, 
whether Hippo signaling is involved in mechanical signaling to influence cell 
differentiation is unknown.   
Here, by deleting Lats1/2 kinases in the Wt1 epicardial lineage, we find that 
Hippo mutant epicardium preferentially generates a highly proliferative 
endothelium. Furthermore, Lats1/2 mutant epicardium had mechanical properties 
and cytoskeletal organization characteristic of cells in a stiff matrix environment 
that also promotes the endothelial fate. Our data reveal that mechanical signaling 
and the Hippo pathway cooperatively determine epicardial specification. 
Materials and Methods 
Mice 
Wt1CreERT2 (9), Lats1/2flox/flox (3), Rosa26mTmG (11) alleles have been 
described previously. Mice were on a mixed genetic background of C57BL/6 and 
129SV. Tamoxifen was dissolved in peanut oil with 5% ethanol at 10mg/ml. For 
Wt1 CreERT2,0.1mg/g body weight tamoxifen was administrated to plugged female 
by intraperitoneal injection at embryonic (E) day11.5.  
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Immunofluorescent staining 
Epicardium-restricted-Lats1/2 mutant embryos (Lats1/2 CKO) were 
generated by crossing Wt1CreERT2 with Lats1/2flox/flox; Rosa26mTmG. Control 
embryos were generated by crossing Wt1CreERT2 with Rosa26mTmG. Embryos were 
collected at E13.5 or E14.5. For immunofluorescence staining, antibodies used 
were as follows: GFP(1:200, Abcam ab290, ab6673), PECAM-1(1:200, BD 
Pharmingen 550274), PDGFR-β (1:100, Cell Signaling Technology, 
3169),Wt1(1:200, Santa Cruz, SC-192), Phalloidin (1:200, Thermo Fisher 
Scientific ,A22287). To visualize specific antigen, far red 647 fluorophor was 
applied. When applications were necessary for green and red spectrum, sections 
were pre-treated with 0.3% H2O2 in PBS for 20min at room temperature to quench 
the endogenous GFP and Tomato signals, which come from reporter line 
Rosa26mTmG.  In some cases, Tyramide Signal Amplification Systems (1:100, 
Perkin Elmer) were applied to amplify signal. Alexa Fluor 647 conjugated Wheat 
Germ Agglutinin (1:200, Life Technologies, W32466) were used for WGA staining. 
Immunofluorescence images were captured on a Leica TCS SP5 confocal 
microscope, N-SIM Super-Resolution Microscope System (Nikon). 3D 
reconstructed images were process by Imaris software provided in Baylor College 
of Medicine Optical Imaging and Vital Microscopy Core. Sample size labeled on 
corresponding bar graph was number of hearts being analyzed. Three field of 
views were analyzed in each heart. 
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Isolation of embryonic epicardial cells 
Embryonic hearts were harvested at E11.5 or E13.5. Whole ventricle was 
placed on culture dishes coated with 1% Type I rat tail collagen (Corning). 
Epicardial cell monolayer was formed after 24 hr and hearts were removed. For 
RNA-seq experiment, explants isolated at E13.5 were cultured for 2 days.  
EdU incorporation assay 
To study cell proliferation, pregnant females were injected with EdU 
(0.5mg) 2hr before harvesting embryos. Hearts were processed as described 
above. EdU incorporation was assayed by Click-it EdU imaging kit (Life 
Technologies). 
Western Blotting 
Protein level was detected by Western Blotting, which was performed as 
previously described(3). Epicardial cell line MEC1 was used for western 
blotting(59). siRNA used were as follows: Non-targeting siRNA(siNC) 
(Dharmacon, D-001810-02-05), Mouse Lats1 (siLats1) (Dharmacon,L-063467-
00),Mouse Lats2 (siLats2)(Dharmacon,L-044602-00) . RNAiMAX (Thermo Fisher 
Scientific) was used for transfection. Cells were treated with siRNA for 48 hours 
and harvest for protein detection. Antibody used for Western Blotting were as 
follows: anti-pYap, anti-MLC, anti-pMLC and anti-Lats1 (Cell Signaling 
Technology), anti-a-tubulin(Sigma).  
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FACS analysis  
To determine the percentage of endothelial cell of initial labeling, pregnant 
females were injected with tamoxifen at E11.5 and embryonic hearts were 
harvested at E12.5 or E14.5. Cells were dissociated as previously described (12). 
Hearts were chopped into several pieces and digested by 1mg/ml collagenase I 
for 20 min at 37 degree. Every 10min, gently pipette sample up and down to 
mechanically dissociate the cells. 10% FBS in DMEM was applied to stop the 
digestion and samples were passed through 100µm strainer. After washed twice 
with 1% FBS in PBS, cells were stained with PECAM-1 (eBioscience 17-0311-80) 
or isotype (eBioscience 17-4321-41) conjugated with APC. Cells were analyzed 
using   BD Biosciences SORP Aria I and BD Biosciences LSRII and images were 
processed with FlowJo software.    
RNA sequencing  
Pregnant females were injected with Tamoxifen at E11.5 and epicardial 
explant culture was performed at E13.5. Wt1CreERT2; Rosa26mTmG/+ embryos 
were used as controls and Wt1CreERT2; Lats1/2 f/f; Rosa26mTmG/+ embryos were 
used as mutant. Two litters of embryos were pooled as one sample. Three 
different samples were collected for each genotype and subjected to RNA 
sequencing. Total RNA was extracted using Qiagen RNeasy micro kit according 
to the manufacturer’s protocol. mRNA was purified by Dynabeads mRNA DIRECT 
Micro Kit(Life Technologies) and then converted to barcoded cDNA libraries for 
RNA sequencing on the Ion Proton System using Ion Total RNA-Seq Kit v2.0(Life 
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Technologies) and RNA-Seq Barcode 01-16 Kit(Life Technologies). RNA-seq was 
performed on Ion Proton. Around 35 million reads were generated for transcripts 
quantification in each sample. Paired-end RNA Seq reads were aligned to mm9 
(Mus musculus assembly July 2007). Raw read counts were normalized and 
analyzed for differential gene expression by DESeq2. GO-seq was used for Gene 
Ontology (GO) analysis to extract the information on gene set and gene network.  
Atomic force microscopy 
Pregnant female were injected with Tamoxifen at E11.5 and hearts were 
isolated at E13.5. Wt1CreERT2; Rosa26mTmG/+ embryos were used as controls and 
Wt1CreERT2; Lats1/2 f/f; Rosa26mTmG/+ embryos were used as mutant. Freshly 
isolated hearts were mounted on poly-l-lysine coated coverslip. All AFM images 
and measurements were taken by Bioscope Catalyst AFM (BRUKER) and 
Olympus IX81 inverted optical microscope located at Houston Methodist 
Research Institute Microscopy-SEM/AFM core. A spherical AFM tip was made by 
attaching a silicon particle with 5µm diameter (Hamilton Company) to a silicon 
nitride cantilever (MLCT, BRUKER) with tip half angle 18º (60) . Spring constant 
was at 0.02N/m calibrated by thermal vibration in air. Deflection sensitivity was at 
77.9nm/V obtained by a standard force-displacement curve in PBS on a silicon 
wafer. Contact mode was conducted and the probe was engaged onto the surface 
of the heart at ramp rate 1Hz without X-Y axis scanning. Each single 
measurement was acquired by the average of 50-100 times of indentation force 
engagement. For each heart tissue, 10 different measurements were performed 
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and 3-4 hearts were measured in control and Lats1/2 CKO hearts. 30-40 
measurements were pooled in each group. Young’s modulus was calculated from 
force displacement curve using Nanoscope analysis software v1.40r2.  
Epicardial cell differentiation assay on tunable stiffness hydrogel  
Epicardial cells were isolated at E11.5 from Lats1/2f/f; 
Rosa26mTmG/Rosa26mTmG embryonic hearts. Tissue was removed after 24hr and 
outgrowth was trypsinized and replated on tunable stiffness hydrogel, which was 
prepared as previously described (61).  Stiffness was adjusted based on the 
relative concentration of acrylamide and bis-acrylamide. Hydrogel were coated 
with type I rat tail collagen (0.5mg/ml) before epicardial explant culture. 1hr after 
seeding cells on hydrogel or plastic dish, cell were either infected with the 
adenovirus packaged by Ad5 empty vector or Ad5-CMV-Cre vector for 48hr. Virus 
was generated by Baylor College of Medicine Vector Development Core Lab. 
Cells were continuously cultured in Endothelial Cell Growth Medium (Lonza) 
supplemented with 50ng/ml b-Fgf (R&D Systems) and 50ng/ml VEGF (R&D 
Systems) for 11 days and medium was changed every two days. Endothelial cells 
were detected by PECAM-1(1:200) immunofluorescence staining.  
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Results 
 
Lats1/2 epicardial deficiency results in elevated proliferation with altered 
epicardial cell diversification  
Our above study has shown Lats1/2 deficiency led to coronary vessel 
defects and reduction of epicardial derived cardiac fibroblast differentiation. To 
investigate how EPDC fate associates with coronary vessel phenotype in more 
depth, we performed lineage tracing using Rosa26mTmG reporter line.  GFP 
immunofluorescence staining was used to co-label epicardial lineage with 
PECAM-1, PDGFRα and PDGFRβ that are markers for endothelial cells, 
fibroblasts and smooth muscle cells respectively. Paraffin tissue sections were 
bleached by 0.3% H2O2 to quench the fluorescence signal from the Rosa26mTmG 
reporter, and the cell lineage specific markers were visualized in far-red spectrum 
to avoid interference from tdTomato (see methods). Unexpectedly, the 
percentage of endothelial cells derived from EPDC was increased from 2.6% in 
control to 12.5% of EPDC in Lats1/2 CKO based on immunofluorescent staining 
and FACS quantification (Figure 3.1 A-B). The increase in endothelial cell number 
came at the expense of fibroblasts and smooth muscle cells, the major Wt1-
expressing epicardially-derived cell types in control hearts. In Lats1/2 CKO 
mutants, fibroblast contribution was reduced as shown in previous study (Figure 
2.23), while smooth muscle cells decreased from 40% to 25% of EPDCs (Figure 
3.2 A-B). 
  
 
 
59 
 
 
 
Figure 3.1 Knocking out Lats1/2 in epicardium leads preferential 
differentiation into endothelial cells. (A) Wt1 lineage was traced by 
GFP expression. Endothelial cell was examined by PECAM-1 
immunofluorescence staining. (B) FACS analysis quantification of the 
percentage of epicardial derived endothelial cells (*P<0.0001 was by 
Chi-square test).  
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Figure 3.2. Lats1/2 deficiency in epicardium results in reduction of smooth 
muscle cell differentiation from epicardial cell. (A) Wt1 lineage was traced by 
GFP expression. Smooth muscle cell was examined by PDGFR-β 
immunofluorescence staining. (B) Quantification of the percentage of epicardial 
derived endothelial cells (*P<0.1 was by Mann-Whitney U test).  
 
 
 
 
 
 
 
 
Endogenous Wt1 expression has been reported in E14.5 endothelial cells, 
which is at a relative late stage (36). Other work indicated that  tamoxifen 
injections in Wt1creert2 mice at E10.5 labeled only a very small percentage of 
endothelial cells (62).  To investigate the source of increased endothelial cells in 
our study, we performed fluorescence-activated cell sorting (FACS) to examine 
 
 
61 
 
 
the endothelial cell labeling 24-hours after tamoxifen induction when nuclear Cre 
activity is maximum (63). In controls, only 0.68% of GFP positive cells were 
PECAM positive, but in Lats1/2 CKO hearts 2.67% of GFP positive cells were 
PECAM positive (Figure 3.3 A-B). This indicates that a minimal number of 
endothelial cells are included in the initial labeling as shown by less than 1% of 
control GFP positive endothelial cells and that Lats 1/2 deletion causes a rapid 
endothelial cell expansion within 24 hours of tamoxifen injection.  
We next examined the proliferation rate in each type of EPDC in more 
depth. In E14.5 control, fibroblasts, smooth muscle cells, and endothelial cells had 
equivalent rates of EdU incorporation (Fig.3.3 C-D). In contrast, Lats1/2 CKO 
endothelial cells had significantly increased EdU incorporation while fibroblasts 
and smooth muscle had similar EdU incorporation rates as the control. Together, 
these data indicate that Lats1/2 deletion in Wt1-expressing epicardium causes a 
rapid increase in endothelial cell proliferation but not fibroblasts or smooth muscle.   
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Figure 3.3. Initial labeling of endothelial cells and proliferation in different EPDC.(A-
B) FACS analyses at E12.5 to examine endothelial cell labelling by Wt1CreERT2 after 
24-hour tamoxifen induction. In Lats1/2 CKO hearts, 2.67% of GFP+ cells was endothelial 
cell, which was significantly higher than 0.68% in the controls (*P<0.0001 was by Chi-
square). (C-D) EdU incorporation rate in three different types of EPDC at E14.5. Triple 
positive cells (PDGFRa+GFP+EdU+; PDGFRb+GFP+EdU+;PECAM+GFP+EdU+) were 
indicated by arrowheads in C. Lats1/2 CKO hearts showed preferentially increased EdU 
incorporation rate in endothelial cells (*P=0.011 in D was by Chi-square) but not in 
fibroblasts and smooth muscle cells. In control, fibroblasts(GFP+PDGFRa+), smooth 
muscle cells(PDGFRb+) and endothelial cells(PECAM+) maintain the same EdU 
incorporation rate, but in the Lats1/2 CKO heart, EdU incorporation was significantly 
higher in endothelial cells than other two cell types(*P=0.015 and 0.005 in E were by Chi-
square). Numbers labelled on each bar graph are the actual observed cell numbers and 
they are proportioned to 100%.  Epi, epicardium; Myo, myocardium. 
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Lats1/2 inactivation resulted in increased cell stiffness 
To gain deeper insight into molecular mechanisms underlying the vascular 
defects in the Lats1/2 CKO mutants, we performed RNA-sequence (seq) using 
primary epicardial explant cells at E13.5(Fig.3.4A) (64). Before subjecting cultured 
cells to RNA-seq and to validate that explants maintained epicardial 
characteristics, explanted cell composition was studied by Wt1 
immunofluoresence that showed the great majority of explanted cells were Wt1 
positive (Fig.3.4B). Moreover, RNA-seq showed that the epicardial marker Wt1 
was highly enriched while the fetal myocardial marker Myh7 was depleted 
(Fig.3.4C).  In addition, the LoxP flanked exons of Lats1 and Lats2 were strongly 
reduced in the Cre treated samples (Fig.3.4 C).  
RNA-seq showed that in Lats1/2 CKO epicardial explants, 167 genes were 
up-regulated and 275 genes were downregulated when compared to wild type 
explants (Fig.3.5A). Subjecting genes with significant expression changes to gene 
ontology analysis revealed that signaling pathways related to vasculogenesis and 
angiogenesis were enriched in the up-regulated gene set. In particular, we noted 
that the FGF, Angiopoietin, and PDGF pathways were upregulated (Figure 3.5 B-
C). These gene expression changes were consistent with the increase in 
endothelial cells that we observed in the Lats1/2 CKO hearts.  
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Figure 3.4. RNA-seq experiment design and quality control. (A)Schematic of 
epicardial cells isolation. (B) Cell identity after 3-day culture. The majority of 
explant culture expressed epicardial cell marker Wt1. (C) Knockout efficiency and 
purity of isolated cells. Gene expression level was represented by normalized 
reads number, RPKM (reads per kilobase per million). The expression level of 
exon4 of Lats1 and exon5 of Lats2. (D)Relative position of explant cells and heart 
in culture. Scale bar 100um. 
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Figure 3.5. Differential gene expression and GO analysis.(A) Differential gene 
expression. In Lats1/2 CKO primary epicardial cells, 167 genes were upregulated 
and 275 genes were downregulated. (B) GO analysis.  Enriched GO terms of up-
regulated genes (upper red bars) and down-regulated genes (bottom blue bars). 
Number on each bar represented the number of genes changed in its 
corresponding term. (C) Heat map of selected differentially expressed genes 
based on the GO terms of interest. Color key represents log-transformed relative 
gene expression level between control and mutant with three biological replicates 
in each group.   
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Gene categories in the down-regulated gene set included collagen and 
extracellular matrix, as well as, blood vessel morphogenesis and branching 
morphogenesis. For example, genes such as Adamts14, Adamts9, Adamtsl2, 
Col7a1, Col8a2, and Emilin that regulate collagen processing and extracellular 
matrix deposition were downregulated. Other genes that promote blood vessel 
morphogenesis such as Heg-1 and Bmx were also downregulated (65,66). These 
changes in gene expression are consistent with the defective vascular 
morphogenesis phenotype with reduced numbers of fibroblasts and smooth 
muscle cells that we observed in Lats1/2 CKO mutant hearts.    
We also noted that genes involved in motor activity, myosin complex, and 
Rho GTPase activity were enriched in the up-regulated data set. Included in these 
categories were dyneins Dynlt-1a and Dynlt-1b that are important in intracellular 
trafficking (67). We noted upregulation of Myo5b encoding a non-muscle myosin 
and a regulatory myosin light chain, Myl12b. Moreover, Cgnl1was upregulated 
and encodes a protein that links actin cytoskeleton to adherens and tight junctions 
(68). We also saw increased expression of the integrin, Itgb4 that encodes a 
protein linking the actin cytoskeleton to the extracellular matrix. As a readout of 
cytoskeleton contractility, we examined the phosphorylation level of myosin light 
chain(p-MLC). Using siRNA against Lats1/2 efficiently to knock down the 
expression of Lats1/2 in epicardial cell line MEC1 cells, we found p-MLC was up-
regulated(Fig.3.6). Together, these findings support the notion that epicardial 
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deletion of Lats1/2 resulted in up-regulated actin and myosin cytoskeletal proteins 
and a more rigid cytoskeleton.  
 
 
 
 
Figure 3.6. Phosphorylation level of MLC is up-regulated in Lats1/2 
knockdown cells.   
 
 
 
To test the idea that Lats1/2 CKO epicardial cells were more rigid than 
control epicardial cells, we directly measured epicardial stiffness in situ in Lats1/2 
CKO and control E13.5 hearts by atomic force microscopy (AFM). A spherical 
AFM cantilever (Fig.3.7 A-B) was pointed to the surface of embryonic heart 
(Fig.3.7 C) and Young’s modulus was generated by force-displacement curve with 
an indentation depth of 1.5µm that reflects the stiffness of cells with negligible 
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effects of the substrate (69,70). We found the stiffness was significantly increased 
in Lats1/2 CKO hearts (Fig.3.7 D).  
 
 
 
 
 
Figure 3.7. Aberrant stiffness in Lats1/2 CKO hearts. (A-B) Images of AFM 
cantilever after attaching a 5µm silicon particle. (C) Epicardial cell stiffness was 
measured by AFM. (D) Increased cell stiffness in Lats1/2 CKO. Original data was 
transformed by Ln to fit normal distribution.  
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Since the state of the cytoskeleton is closely related to cell shape, we 
examined cell shape used wheat germ agglutinin (WGA) staining. Control 
epicardial cells had a flat and compact morphology while the Lats1/2 CKO mutant 
epicardial cells had a spherical shaped (Fig.3.8A). We next stained F-actin by 
phalloidin and reconstructed our confocal images into 3D and used super 
resolution microscopy to further evaluate cell morphology. While the control 
epicardial cells had a flat morphology with F-actin distributed with a slight 
preference for the basal aspect of the cell the spherical Lats1/2 CKO epicardial 
cells contained a large amount of basal F-actin with nuclei pushed to one side of 
the cell (Fig.3.8 B). The change of F-actin was further validated by FACS analysis 
to examine intensity phalloidin dye which stains F-actin in epicardial cells. Lats1/2 
CKO cells showed enhanced phalloidin intensity(Fig.3.9). Taken together, these 
findings indicate that Lats1/2 deletion in epicardium results in a more rigid 
cytoskeleton with excessive F-actin.  
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Figure 3.8. Disorganized F-actin and rounded cell shape in Lats1/2 CKO 
epicardial cells. (A-B) Cell boundary was delineated by WGA staining. In Lats1/2 
CKO, epicardial cell shape became rounded compared with control (arrows). (E-
F) Images of super-resolution microscopy found rounded cell shape and 
accumulation of F-actin in Lats1/2 CKO epicardial cells. 
 
 
 
 
Figure 3.9. Enhanced F-actin intensity in Lats1/2 CKO epicardial cells by 
FACS analysis.  
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Hippo pathway and mechanical signaling coordinately determine EPDC 
diversification 
Up to this point, our data suggest that Lats1/2 CKO mutant epicardial cells 
have a stiffer cytoskeleton that promotes endothelial cell expansion. The Lats1/2 
CKO mutant cells with their stiffer cytoskeleton have characteristics of cells found 
on a stiff extracellular matrix since cells respond to stiff matrix by making a more 
rigid cytoskeleton. The prediction from this would be that epicardial cells cultured 
on a stiff matrix will form endothelial cells at a higher frequency than cells on a 
softer, more physiologic matrix. Also since Lats1/2 CKO cells already have a rigid 
cytoskeleton they should form endothelial cells on a softer matrix.  
To test these predictions, we plated epicardial cells on a tunable stiffness 
matrix. We isolated epicardial cells from Lats1/2 flox/flox; Rosa26mTmG embryos and 
infected them with an Adenovirus (Ad5) empty vector as control or Ad5-CMV-Cre 
to delete Lats1/2 in vitro. Cells were grown on the stiff plastic substrate or the 
softer, physiologic-relevant 4 kilopascal (KPa) matrix to compare the influence of 
matrix stiffness on cell fate (Fig.3.10 A). When cells were grown on the plastic 
substrate both control and Lats1/2 mutant epicardial cells were equivalently driven 
to become endothelial cells regardless of Lats kinase activity (Fig.3.10 B, C, F). 
In contrast, for cells grown on 4KPa that approximates physiologic stiffness in 
vivo, Lats1/2 mutant cells but not control cells more frequently acquired the 
endothelial phenotype (Fig.3.10 D-F). Together, these findings indicate that 
biomechanical properties of the extracellular matrix are a major determinant of 
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epicardial cell diversification and that Hippo signaling acts to reduce cytoskeletal 
rigidity to inhibit endothelial cell proliferation. 
 
 
 
 
Figure 3.10.  Lats kinase cooperates with matrix stiffness to regulate EPDC fate. (A) 
Workflow of inducing epicardial cell into endothelial cell. (B-F) GFP represented Lats1/2 deficient 
cells. Endothelial cells identity were observed using PECAM-1 after 11-day culture. On plastic 
substrate, control and Lats1/2 deficient epicardial cells both equivalently gave rise to endothelial 
cells. On 4KPa, increased endothelial cells derive from epicardial cells after knocking out Lats1/2. 
Sample size=5. Data are means ± SD. *P=0.034 and #P= 0.007 were by Mann-Whitney U test. 
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Discussion 
Mechanical signaling affects cell morphology and cell fate in mesenchymal 
stem cells in vitro (71). Here, we show that diversification of epicardial progenitor 
cells are sensitive to mechanical signaling. Lats kinase activity inhibits 
proliferation of endothelial cells depending upon the state of the actin 
cytoskeleton. At physiologic mechanical stress, Lats represses endothelial cell 
expansion but loses its inhibitory activity under high mechanical stress.  
Mechanical signaling determines epicardial diversification 
Our findings indicate that at E10.5-E11.5, after epicardial cells attach onto 
the myocardium and undergo EMT, Lats1/2 maintain epicardial cells in a specific 
mechanical state that determines their flat compact shape that is critical to 
promote smooth muscle and fibroblast development (Figure 3.11). In Lats1/2 
mutants, epicardial cells have a more rigid cytoskeleton as directly measured by 
AFM. The super-resolution images further support the notion that Lats1/2 mutant 
epicardial cells had a stiffer cytoskeleton since mutant epicardial cells expressed 
excessive intracellular actin bundles and the nucleus was pushed to one side.  
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Figure 3.11. Schematic model of Hippo-mechanical dependent epicardial 
cell proliferation regulation. On soft matrix or physical relevant stiffness, Lats is 
recruited to the plasma membrane to inhibit Yap nuclear activity, which is 
speculated to initiate endothelial cell (EC) expansion with assistance of unknown 
transcription factor(s). Lats also exerts its inhibitory effect on F-actin 
polymerization, which is known to promote Yap nuclear activity. On hard matrix, 
Lats dissociates from plasma membrane and loses its inhibition on Yap and F-
actin polymerization. Therefore, Lats kinase inhibitory activity on EC proliferation 
becomes dispensable.   
 
 
 
The change in epicardial development observed in Lats1/2 mutants 
resulted in fewer fibroblasts and smooth muscle cells that are important supporting 
cells for myocardium and vasculature. The lack of these essential supporting cells 
likely contributes to the failure of myocardial development with smaller hearts and 
embryonic lethality. Moreover, endothelial cells in Lats1/2 mutants fail to complete 
tubulogenesis and branching morphogenesis. In addition to the reduction in the 
number of smooth muscle cells, our RNA-seq data showed that Lats1/2 mutant 
epicardium expressed elevated levels of genes encoding components of the pro-
vasculogenic FGF, Angiopoietin and PDGF pathways. Despite this, other genes 
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that are important for vascular morphogenesis, such as Heg-1 and Bmx, were 
reduced and this undoubtedly contributed to failure of normal vascular 
morphogenesis.  
Hippo pathway intersects with mechanical signaling in epicardial cells  
Mechanical cues and actin cytoskeletal status have been identified as 
upstream inputs into Hippo signaling and/or Yap subcellular localization (57). With 
the exception of one study investigating Yap subcellular localization in a mixed 
cardiac cell population, there is little known about the interplay of mechanical 
signaling and Hippo signaling in the heart (72). Our findings suggest that in 
epicardial progenitors, the status of the cytoskeleton determines whether Lats 
inhibits endothelial cell proliferation. On a soft substrate of 4 KPa, Lats kinases 
inhibit endothelial development. In contrast, when epicardial explants were 
cultured on plastic, modeling a stiff matrix, endothelial markers were expressed 
whether or not Lats activity was present. These data suggest that Lats activity is 
dispensable when cells are cultured on stiff matrix and express large amounts of 
polymerized actin.  
Based on experiments performed in Drosophila, one possible explanation 
is that Lats is recruited to the plasma membrane and activated, perhaps by 
Neurofibromatosis 2 (Nf2), in cells that have less polymerized actin (73). Actin 
cytoskeletal disruption using the actin polymerization inhibitor Latrunculin B 
promotes recruitment of Lats by Nf2 to the plasma membrane with activation of 
Lats kinase activity. In epicardial cells on a softer, physiologic substrate, Lats 
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inhibits endothelial cell proliferation while promoting a less rigid cytoskeletal 
organization and Yap cytosolic localization (Figure 7). Further work is required to 
determine if Nf2 recruits Lats kinases in the epicardium. An alternative possibility 
is that polymerized F-actin induces a Lats kinase inhibitory activity. In conditions, 
such as a soft extracellular matrix where there is less polymerized actin within the 
cell, the repressive activity inhibiting Lats kinase is lost (74). 
It is also notable that inactivation of the serum response factor (SRF) 
cofactor myocardin related transcription factor (MRTF) in epicardium results in a 
strong phenotype that has some similarities to what we observe in the Lats1/2 
epicardial mutants (75). Like Yap and Taz, the SRF-MRTF factors respond to 
mechanical signaling and have been reported to have overlapping target genes 
to that of Yap and Taz (76). It will be interesting to investigate potential functional 
overlap between Yap/Taz and MRTF in more depth.    
Hippo signaling regulates the cellular mechanical state   
Our study highlights the notion that in addition to being regulated by 
cytoskeleton, Hippo signaling can also affect cytoskeleton organization and 
cellular mechanical properties. It has been shown that loss of function mutations 
in Hippo core kinases leads to increased F-actin accumulation in the Drosophila 
wing disc (77).  In our study, we found that the transcripts of genes associated 
with actin are upregulated, such as genes encoding Dynein motor proteins, the 
actin-contractility regulators Pak6 and Myl12b, and the Cgnl1 actin binding protein 
that links actin to adherens and tight junctions. Recent data indicate that Yap can 
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directly regulate genes that promote actin polymerization in the myocardium (2).  
It is conceivable that in the epicardium Yap also promotes expression of genes 
that enhance actin polymerization and promote cellular protrusions.  
Epicardial plasticity and contribution to coronary endothelium  
Under physiologic conditions, Wt1-lineage epicardial precursors contribute 
very few cells to coronary endothelial cells (reviewed in (78)). Our findings indicate 
that the Wt1-lineage epicardium does have the potential to generate coronary 
endothelial cells but that the Hippo pathway represses endothelial cell 
proliferation. Interestingly, our findings support the notion that Hippo pathway 
repression can be released by increases in mechanical signaling. Therefore, the 
Hippo pathway, cytoskeleton and perhaps extracellular matrix strike a balance to 
maintain the epicardial development into smooth muscle and fibroblasts.  
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CHAPTER IV 
HIPPO KINASE LATS IS REQUIRED IN ADULT HEART HOMEOSTASIS 
MAINTENANCE AND INJURY RESPONSE 
Introduction 
Unlike lower vertebrates, adult mammalian heart has very limited 
regeneration capacity. Once heart is injured, myocardium will be replaced with 
fibrotic scar and heart function will be deteriorating with disease progressing. 
Currently, most studies have been focusing on cardiomyocytes. However, cardiac 
fibroblasts, which contribute to fibrosis per se, is under studied. As one of most 
prevalent cell types in heart, except its role in producing extracellular matrix to 
support heart structure, the cross-talk of cardiac fibroblast with other cell types 
during homeostasis and injury response is not well recognized.  
Hippo signaling is a highly conserved pathway in limiting organ size through 
regulating cell proliferation and apoptosis. Here is our study, under non-injury 
condition, we inactivated potent Hippo signaling kinases Lats1/2 specifically in 
cardiac fibroblast. The homeostatic balance between fibroblasts and other cell 
types was disrupted by pronounced expansion of Lats1/2 deficient fibroblasts. By 
this genetic model, we disclosed an interaction between fibroblasts and immune 
cells. Additionally, we found Lats1/2 kinases are required to suppress Myc 
expression to prevent elimination of less competitive neighboring cells. Under 
ischemia stress, the effect of loss of Lats1/2 was augmented. Collectively, our 
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data revealed an essential function of Lats1/2 kinase in cardiac fibroblast under 
homeostasis, which also prepare fibroblasts for injury response.   
Materials and Methods 
Mice 
Tcf21iCre(31), Lats1/2flox/flox (3), Yap/Taz flox/flox(10),Rosa26mTmG (11) alleles 
have been described previously. Mice were on a mixed genetic background of 
C57BL/6 and 129SV. Tamoxifen was dissolved in peanut oil with 5% ethanol at 
10mg/ml. 3mg tamoxifen was administrated to 6-8 week old mice by 
intraperitoneal injection for 6 days.  
Echocardiography 
Cardiac function was analyzed by echocardiography every week post 
surgery. Imaging were performed on VisualSonics Vevo 2100 system with 550-s 
probe. B-mode images and M-mode images were captured on short-axis 
projection. Ejection fraction, fraction shortening, and cardiac output were 
calculated using cardiac measurement package installed in Vevo2100 system. 
Histology and immunofluorescence 
Fibroblast-specific-Lats1/2 mutant mice (Lats1/2 CKO) were generated by 
crossing Tcf21iCre with Lats1/2flox/flox; Rosa26mTmG. Control were generated by 
crossing Tcf21iCre with Rosa26mTmG. For histology and immunofluorescence 
staining, hearts were fixed in 4% PFA overnight at 4°C and dehydrated in a serial 
ethanol, xylene and embedded in paraffin. Sections of 7µm thick sections were 
prepared for staining. Masson’s Trichrome staining was performed according to 
 
 
80 
 
 
manufacture’s instruction (Sigma, HT15). Antibodies used for 
immunofluorescence staining were as follows: GFP (1:200, Abcam ab290, 
ab6673), PECAM-1(1:100-1:200, BD Pharmingen 550274), c-Myc [Y69](Abcam, 
ab32072). To visualize some antigens, Alexa-647 was employed. When 
applications required green and red co-staining, sections were pre-treated with 
0.3% H2O2 in PBS for 20min at room temperature to quench the endogenous GFP 
and Tomato signals, which come from the Rosa26mTmG reporter line.  In some 
cases, Tyramide Signal Amplification Systems (1:100, Perkin Elmer) were used 
to amplify signal. TUNEL assay was performed according to manufacture’s 
instruction (Progema, G3250). Immunofluorescence images were captured on a 
Leica TCS SP5 confocal microscope.  
EdU incorporation assay 
Mice after MI were injected with EdU (0.5mg) 24hr before collecting heart 
tissue. Hearts were processed as described above. EdU incorporation was 
assayed by Click-it EdU imaging kit (Life Technologies). 
Western Blotting 
Protein level was detected by Western Blotting, which was performed as 
previously described(3). Mouse fibroblast cells line NIH3T3 was used for western 
blotting(ATCC®CRL-1658). siRNA used were as follows: Non-targeting 
siRNA(siNC) (Dharmacon, D-001810-02-05), Mouse Lats1 (siLats1) 
(Dharmacon,L-063467-00),mouse Lats2 (siLats2)(Dharmacon,L-044602-00) and 
mouse Myc (Dharmacon). RNAiMAX (Thermo Fisher Scientific) was used for 
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transfection. Cells were treated with siRNA for 48 hours and harvest for protein 
detection. Antibody used for Western Blotting were as follows: anti-Myc(Abcam), 
anti-Lats1 (Cell Signaling Technology), Gapdh(Abcam).  
FACS analysis for cell cycle  
Cardiac fibroblasts were isolated from hearts at 1 week post MI by 
langendorff perfusion. GFP positive cells were gated for analysis and DAPI were 
used for analyzing DNA content. FACS were performed on BD Biosciences SORP 
Aria I and BD Biosciences LSRII and cell cycle modelling were processed with 
FlowJo software.    
RNA sequencing  
For TRAP/Ribosome-associated RNA-seq, RNA pull-down from 1week 
post MI herats were performed according to McKnight Lab protocol 
(http://depts.washington.edu/mcklab/RiboTag.html).  Anti-HA antibody (Cell 
signaling technologies) were used for pull-down. Ribosome-associated mRNA 
were extracted using RNeasy Plus Micro Kit(Qiagen). mRNA were further purified 
by Dynabeads mRNA DIRECT Micro Kit (Life Technologies) and then converted 
to barcoded cDNA libraries for RNA sequencing on the Ion Proton System using 
Ion Total RNA-Seq Kit v2.0(Life Technologies) and RNA-Seq Barcode 01-16 
Kit(Life Technologies). RNA-seq was performed on Ion Proton. Around 12 million 
reads were generated for transcripts quantification in each sample. Paired-end 
RNA Seq reads were aligned to mm9 (Mus musculus assembly July 2007). Raw 
read counts were normalized and analyzed for differential gene expression by 
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DESeq2. Metascape (http://metascape.org/) was used for Gene Ontology (GO) 
analysis to extract the information on gene set and gene network. R and RStudio 
were used for generating heatmap.  
For FACS-sorted RNA-seq, GFP positive cells were isolated using 
Langendorff perfusion of heart 3 days after 6-dose tamoxifen injection. Because 
of limited GFP cells, sorted cells were directly collected in RLT lysis buffer from 
RNeasy Plus Micro Kit (Qiagen) and SMART-Seq Ultra Low Input RNA Kit to 
prepare RNA-seq library (Clonetech Laboratories). Sequencing and analysis 
procedures were same as above for TRAP RNA-seq.  
Results 
Deficiency of Lats1/2 in adult cardiac fibroblast results in abnormal tissue 
accumulation and injury response  
To investigate the function of Lats1/2 kinases in adult cardiac fibroblast, we 
used Tcf21iCre to inactivate Lats1/2 in cardiac fibroblast at adult stage. Cre 
activity was induced by tamoxifen injection. We subjected these animals for either 
sham or myocardial infarction surgery to examine the role of Lats1/2 in 
homeostasis and injury response (Fig.4.1 A).  In sham group, majority of Lats1/2 
CKO mice maintained alive until 3 weeks after surgery. However, in MI group by 
occluding left descending artery (LAD-O), all mutant mice died by 3 weeks after 
ischemia (Fig.4.1 B).  Gross heart morphology of sham mutant heart at end stage 
(3 weeks after surgery) (Fig.4.2 A, left) showed aberrant patch-pattern like white 
tissue in ventricles(star), and atria were pale, enlarged and stiffened. Right atrium 
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displayed much more severe abnormality(star). Surprisingly, MI mutant 
significantly exacerbated this phenotype in sham hearts (Fig.4.2, right), abnormal 
tissue accumulation expanded to the most region below the suture where artery 
occlusion performed(star). Atria in MI heart also had similar stiffened and enlarged 
morphology as in sham especially right atrium(star).  
 
 
 
 
 
Figure 4.1 Experiment design and survival rate. (A) Adult mice at 6-8 week old were 
subjected to 6 consecutive dose of tamoxifen. Sham or MI surgery was performed after. 
Heart function was monitored by echocardiography every wek after surgery and tissues 
were collected at 3 weeks post surgery. (B) Survival rate of control (blue line) and Lats1/2 
CKO mice (red line) in sham group (left) and MI group(right) (*p<0.01 by Kaplan-Meier 
survival curve analysis). 
 
 
 
84 
 
 
We sectioned these hearts and examined histology by Masson’s Trichrome 
staining. In sham group (Fig.4.2 left), the aberrant tissue accumulation in Lats1/2 
CKO hearts, mainly located at outer and inner surface of ventricular wall(stars). 
The accumulation at latter spot resulted in significant cardiac lumen restriction. 
These abnormal spots are not stained red compared with sham control, 
suggesting they are lack of muscle features.  More profoundly, in MI group (Fig.4.2 
right), instead of a compact scar formation after MI in control hearts(arrow), the 
region below the ligation was almost completely replaced with this aberrant type 
of tissue(star), and little myocardium and cardiac lumen were maintained. We 
reduced the activity of Lats1/2 downstream effector Yap/Taz by creating 
heterozygous alleles Yap and Taz and found the phenotype was partially rescued 
and some myocardium were maintained. This suggests Yap/Taz mediated the 
effect of Lats1/2 deficiency. Moreover, within this abnormal tissue, we did not 
detect obvious collagen deposition, which results from injury response and scar 
formation, as blue stained in control MI hearts. Cardiac function monitored by 
ultrasound also showed consistent change. In Sham group(Fig.4.3 upper row), 
ejection fraction and fraction shortening were enhanced in mutant hearts, which 
probably are attributed to ventricular wall thickening and increase of contractility 
to compensate lumen restriction. Nonetheless, cardiac output, which is an index 
reflecting overall volume of blood pumped by heart per minutes, was significantly 
reduced in both sham (Fig.4.3 upper row) and MI groups (Fig.4.3 bottom row).  
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Taken together these data elucidate that Lats1/2 in adult cardiac fibroblast is 
required for maintaining tissue homeostasis and normal response to ischemia.   
 
 
 
 
Figure 4.2. Gross heart morphology and histology. (A) Gross heart morphology at 3 weeks 
post surgery. Lats1/2 CKO hearts in sham group (left) showed abnormal tissue accumulation. Atria 
were stiffened and enlarged(stars). Lats1/2 CKO hearts in MI group (right) had a more profound 
phenotype with aberrant tissue expansion below the artery ligation(starts). Atria also appeared 
loss of compliance. (B) Histology was examined by Masson’s Trichrome Staining. Red stains 
muscle and blue stains collagen. In sham group(left), abnormal tissue located at outer and inner 
surface of heart and resulted in cardiac lumen restriction. In MI group, control hearts were with 
compact scar (arrowheads), but mutant hearts displayed significant aberrant tissue expansion 
which resulted in disappearance of cardiac lumen(stars).  Reducing activity of Yap/Taz seemed to 
partially rescue severity of phenotype of Lats1/2 CKO hearts. Some myocardium was maintained. 
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Figure 4.3. Cardiac function monitored by echocardiography. In sham group 
(upper row), ejection fraction and fraction shortening were enhanced but cardiac 
output was reduced in Lats1/2 CKO (red lines) compared with control (blue lines). 
MI group (bottom row) mutant showed reduction of cardiac output since first week 
after surgery (t-test, *p<0.01). 
 
 
 
 
Deficiency of Lats1/2 unleashes cardiac fibroblast proliferation capacity and 
defective collagen deposition 
To gain the insight of molecular mechanism of Lats1/2 CKO heart phenotype, we 
performed Translating Ribosome Affinity Purification (TRAP)/RiboTag RNA-seq. 
At 1 week after MI, RNA associated with translating ribosome was purified and 
subjected to RNA-seq (Fig. 4.4 A). Gene Ontology(GO) analysis of differential 
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expressed genes showed gene associated with cell cycle, DNA metabolic process 
and ribosomal biogenesis were significantly up-regulated. Meanwhile, 
extracellular matrix organization, and actin filament-based process, and blood 
circulation associated genes, which are the key process of injury response, were 
greatly down-regulated (Fig.4.4 B). To validate our findings in RNA-seq, we 
examined DNA synthesis and cell cycle in Lats1/2 deficient cells. EdU 
incorporation was performed 1day, 3days, 5 days and 7 days post MI(Fig.4.5). 
GFP from Rosa26mTmG  allele was used to trace fibroblast upon cre activation. We 
found in control hearts, at Day3, fibroblasts reached the peak of active DNA 
synthesis, and gradually tapered off at Day5. Interestingly, Lats1/2 CKO showed 
similar DNA synthesis rate until Day3, but kept elevating at Day5 and maintained 
high at Day7.  In addition, great amount of GFP positive cells distributed in patch 
pattern in mutant heart (Fig.4.5A Day7 Lats1/2 CKO), corresponding to the the 
area of aberrant tissue we observed in histology, which suggests the origin of the 
tissue is mutant cardiac fibroblast.  
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Figure 4.4. Translating Ribosome Affinity Purification (TRAP)/RiboTag RNA-
seq. (A)Working flow of TRAP RNA-seq. (B) GO analysis of differentially 
expressed genes from TRAP RNA-seq.  
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Figure 4.5. EdU incorporation assay. (A)EdU was inject 24 hours before tissue 
collection. Heart at 1 day, 3 days, 5 days and 7 days post MI were harvested. GFP 
labels Tcf21 derived cardiac fibroblasts and co-stained with EdU. (B) 
Quantification of EdU positive cardiac fibroblast over time.  
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We also analyzed cardiac fibroblast cell cycle by FACS at 7 days post MI 
(Fig.4.6).   According to DNA content, we assigned cells with 2N and 4N into G1 
and G2/M phase respectively, cells with DAPI intensity in between 2N and 4N to 
S phase, and cell with DNA content more than 4N to super G2 phase. In the 
Lats1/2 CKO hearts, more cardiac fibroblast distributed at S phase and less in G1 
phase, which suggest more cells involve in active cell cycle. To be noted, for the 
portion of cell in super G2, which is a readout of polyploidy and genome instability 
of malignant tumor, differences were not significant between control and mutant. 
Indeed, inactivation of Hippo components Lats1/2 has been reported in several 
tumor model, while here the data suggests removing Lats1/2 in cardiac fibroblast 
results in fibroblast hyperproliferation but has not yet to become cancer cell. 
Another finding from RNA-seq was loss of collagen deposition in mutant heart, 
and Masson’s Trichrome staining further corroborated this(Fig.4.7). Taken 
together, we concluded that inactivating Lats1/2 tremendously unleashes cardiac 
fibroblast proliferation capacity and impaired ischemia induced collagen 
deposition.  
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Figure 4.6. FACS analysis of caridiac fibroblast 1 week post MI. (A) GFP 
positive cells different cell phase distribution. (B-C) Composition of cells at 
different cell cycle phases. *p<0.05 by Chi-square test.  
 
 
 
Figure 4.7. Masson’s Trichrome staining of heart 3 week post MI. Red stains 
cardiac muscle and blue stains collagen deposition.   
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Lats1/2 inactivation leads to Myc activation and death of non-cardiac 
fibroblast 
To capture early molecular event and dissect Lats1/2 inactivation from MI 
induced phenotype, we focused on 3 days post tamoxifen injected heart. GFP 
positive cells were sorted and subjected to RNA-seq analysis. Consistent with 
TRAP RNA-seq, whose cells were collected at 1 week after MI, Lats1/2 CKO cells 
showed significant increase of cell cycle genes. Notably, this dataset also 
revealed Myc target genes were up-regulated, suggesting Myc is an immediate 
effector of Lats1/2 deficiency (Fig.4.8, upper panel).  Interestingly, in the down-
regulated genes, we uncovered interferon responding genes and innate immune 
response genes, and genes associated with T cell activation (Fig.4.8, lower panel, 
Fig.4.9), which suggests a regulatory role of fibroblast on immune cells and cross-
talk between these two cell types. 
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Figure 4.8. GO analysis of differential expressed genes 
from isolated fibroblasts of hearts 3 days after tamoxifen 
injection. (Upper panel, red), up-regulated genes in Lats1/2 
CKO cells compared with control includes genes associated 
with cell cycle and Myc targets; (Lower panel, blue), down-
regulated genes in Lats1/2 CKO cells compared with control 
contains genes associated with immune response and 
extracellular matrix organization.  
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Figure 4.9 Interferon responding genes and innate immune regulatory genes 
were down-regulated.  
 
 
 
 
We next validated the c-Myc expression level in vitro and in vivo.  We used 
siRNA to knockdown Lats1/2 in mouse fibroblast cell line 3T3 cells and c-Myc 
were increased in cells treated with siRNA against Lats1/2(Fig.4.10). We also 
examined c-Myc on tissue sections from heart without surgery. We found mutant 
cells which were GFP positive had significantly enhanced c-Myc level (Fig.4.11).  
 
 
95 
 
 
 
Figure 4.10. Increased c-Myc expression in Lats1/2 knockdown cells. NIH 
3T3 cells were treated with siRNA against Lats and cells were hearvested 
48hours. Protein level was detected by Western blotting.   
 
 
 
 
 
 
Figure 4.11. Enhanced c-Myc expression in Lats1/2 deficient fibroblasts. 
Tissue were collect at 3 week post tamoxifen. GFP labelled Tcf21 derived cells. 
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Since c-Myc has been shown to act together with Hippo signaling 
component TEAD to drive cell competition(79), and blood vessel associated 
genes were down-regulated in TRAP RNA-seq (Fig.4.4), we performed PECAM 
staining to detect endothelial cell distribution. In control hearts or intact 
myocardium in mutant hearts, endothelial cells were densely distributed.  
However, in the region where abnormally occupied by hyperproliferative mutant 
fibroblasts showed sparse endothelial cells(Fig.4.12). Furthermore, TUNEL assay 
for detecting cell apoptosis demonstrated significantly increased cell death in 
Lats1/2 CKO hearts, and this mainly took place in GFP negative, non-cardiac 
fibroblasts (Fig.4.13).  Collectively, these data suggested cell competitive 
interaction between super competitor Lats1/2 deficient fibroblasts and other weak 
competitors such as endothelial cells, which was eliminated by cell apoptosis.  
 
 
  
 
Figure 4.12 Reduction of endothelial cell density in Lats1/2 CKO hearts. 
Regions with abnormal tissue accumulation in Lats1/2 CKO showed reduced 
endothelial cell density(star). Tissue were collect at 3 week post tamoxifen. GFP 
labelled Tcf21 derived cells.  
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Figure 4.13. Pronounced cell death in Lats1/2 CKO hearts detected by 
TUNEL assay. TUNEL staining (red, arrows, left three columns) indicated cell 
apoptosis and GFP labelled Tcf21 derived cells. Cell death was mainly in non-
cardiac fibroblasts (arrowheads, right column). Tissue were collect at 3 week post 
tamoxifen.  
 
 
 
 
  
Discussion 
Interferon mediated cross-talk between fibroblast and immune cell 
As two major cell types involving injury response and cardiac fibrosis, 
fibroblasts and immune cells their studies mostly have been done under injury 
model. However, little is know about how they are at resting condition to interact 
with each other and maintain homeostatic balance. Investigating the interaction 
mechanism at resting condition would help us understand the disease progression 
when this balance is disrupted, such as myocardial infarction.  
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Previously studies have shown that mesenchymal stromal cells and 
fibroblast are not immunologically inert. However, to exert immunoregulatory 
effect, they have to be exposed to certain inflammatory milieu as a prerequisite.   
Here in our study Lats1/2 deficient genetic model specifically in cardiac 
fibroblast resulted in abnormal cardiac fibroblast expansion. It appeared to be a 
good interfering model to interrupt the interaction between fibroblasts and other 
cell types. Surprisingly, Lats1/2 CKO fibroblasts showed significantly down-
regulation of the genes responding to inflammatory cytokines interferon gamma 
and interferon beta, such as Ifi202b, Ifi203, Ifi204, Aim2, Irf1, Irf7 and Irf9(80-82). 
These data suggest that fibroblasts are constantly under the stimulation of 
immune cytokines, which are partly from resident immune cells. On the other 
hand, we also observed the immunoregulatory role of fibroblasts were attenuated 
as well. Chemokine Cxcl16, major histocompatibility complex (MHC), class I, and 
hemochromatosis protein Hfe, which are associated with T cell activation and 
MHC I antigen presentation were down-regulated(83,84).  
Overall, our data support a model that the crosstalk between cardiac 
fibroblast and resident immune cells in the heart under homeostasis is mainly 
mediated through interferon family.   
Cell competition and cardiac homeostasis 
Cell competition is an evolutionarily conserved mechanism to maintain 
tissue homeostasis that “fit” cells with higher anabolic capacity eliminate “unfit” 
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cells with lower anabolic capacity(85). Cell with relatively higher activity of Myc 
are supercompetitor which induce death of their neighboring cells(86).Hippo 
signaling components TEAD and Yap have been shown to initiate cell 
competition(79). However, all these studies are either studied in Drosophila, or in 
vitro system.  
Here we exhibited a good system for studying Hippo signaling and cell 
competition in vivo. In Lats1/2 deficient fibroblasts, we observed pronounced Myc 
up-regulation, while non-mutant cell in Lats1/2 CKO hearts, such as endothelial 
cells, number decreased. Importantly, these non-mutant regions showed high 
apoptosis rate, which agrees with typical cell competition phenotype. So far very 
few cell competition studies in heart, and our study is the first time to offer an 
insight of cell competition among different cardiac cell types. although the 
mechanisms of inducing non-mutant cell death remain to be elucidated.  
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CHAPTER V 
SUMMARY 
In our studies, we uncovered an essential of Hippo signaling Kinase 
Lats1/2 in epicardial development and adult heart homeostasis. During epicardial 
development, Lats1/2 kinases is required to maintain fibroblast and smooth 
muscle cell differentiation. Moreover, Lats1/2 kinases and mechanical stress 
coordinately suppress endothelial fate derived from epicardium. In adult heart, 
Lats1/2 in cardiac fibroblast is essential for heart homeostasis. It prevents cardiac 
fibroblast from over-proliferation and maintains normal fibroblast function such as 
collagen production. It is required for common cross-talk between fibroblast and 
immune cells and inhibits of Myc activity from hyperactivated cell-competition.  
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